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Abstract 
In advanced stages of Parkinson Disease (PD), gait and postural abnormalities emerge. These 
symptoms are not prominent at early stages of PD despite significant dopaminergic neuronal 
loss. Gait abnormalities are largely not responsive to levodopa. Therefore, other types of 
neurons might be responsible for gait abnormalities of the PD. 
Since the reticulospinal tract (RET) is mainly implicated in the control of axial muscles, the 
degeneration of this pathway or populations of neurons controlling this pathway might be 
responsible for axial symptoms. However, there is limited data about the neurons controlling 
the RET. Our aim in this study is to delineate these pathways. 
We found that serotonergic projections from dorsal raphe nucleus (DRN) exert an important 
control on the RET. Inhibition of the DRN resulted in severe episodes of gait freezing in rats. 
Activation of 5HT1A receptors in the gigantocellular neurons changes muscle tone in rats 
during gait. The DRN also sends projections to the mesencephalic locomotor region, which 
are implicated in controlling dynamic gait parameters. DRN neurons receive nigral 
dopaminergic projections and post-mortem studies in PD patients have identified significant 
loss of DRN neurons; therefore DRN neurons may play a role in the pathophysiology of gait 
abnormalities of PD.  
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Chapter 1  
1 «                      « General Introduction » 
Parkinson disease (PD) is the second most common neurodegenerative disease after 
Alzheimer disease, affecting approximately seven million people worldwide. During the 
early stages of PD, more than 80% of dopaminergic neurons in the substantia nigra pars 
compacta are lost. This loss of dopamine leads to an array of motor symptoms, including 
tremor, rigidity, and bradykinesia (Berg et al., 2015; Racette & Willis, 2015). 
 
In advanced stages of PD, gait dysfunction, balance abnormalities, and impaired control 
of complex movements emerge. These symptoms are not prominent in the early stages of 
PD despite significant dopaminergic neuronal loss. Although levodopa is the main 
therapeutic treatment to treat PD motor symptoms, gait abnormalities are largely not 
responsive to this drug. Therefore, the postural and gait abnormalities of PD are not 
believed to be isolated to dopaminergic cell loss (Sarter, Albin, Kucinski, & Lustig, 2014; 
Virmani, Moskowitz, Vonsattel, & Fahn, 2015; Vorovenci, Biundo, & Antonini, 2015). 
 
The reticulospinal tract (RET) is a well-known pathway implicated in locomotion, 
postural adjustments, and reaching. This pathway regulates gross motor functions by 
controlling motoneurons and central pattern generators (CPGs) of proximal and axial 
muscles (Baker, 2011b; Schepens & Drew, 2004). Therefore, degeneration of this 
pathway or the population of the neurons controlling this pathway might be responsible 
for axial symptoms in advanced stages of PD.  
 
Neuroanatomical studies have shown that the mesencephalic locomotor region (MLR) 
and specifically the pedunculopontine nucleus (PPN) send projections down to the 
gigantocellular nucleus (GiN), where the RET originates in the medulla (Skinner & 
Garcia-Rill, 1984; Smetana, Juvin, Dubuc, & Alford, 2010); However, no study has 
comprehensively investigated the connections between the PPN, other brainstem nuclei 
and the CPGs and motoneurons of the spinal cord. In addition, several studies have 
suggested that other populations of neurons including serotonergic neurons in the dorsal 
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raphe nucleus (DRN) have a significant role in controlling motoneurons and locomotor 
CPGs (Barreiro-Iglesias, Villar-Cerviño, Anadón, & Rodicio, 2008; Courtine et al., 2009; 
Ghosh & Pearse, 2015).  
In the next section, the role of CPGs, the serotonergic system and DRN, MLR, and GiN 
in gait will be reviewed in detail. 
 
 
 
 
1.1 « Central Pattern Generators » 
There are two main states in all species of animals: 1) quiescence or sleep state and 2) 
active or awake state. During each of these states, there are specific groups of neurons 
that control basic repetitive behaviors such as respiration, swallowing, mastication, 
locomotion, escape, as well as other rhythmic behaviors essential to the animals’ survival 
(Gillette & Brown, 2015) 
To generate rhythmic motor activities, precise spatiotemporal activation and inhibition of 
neurons controlling these behaviors are needed. Such synchronization is the first 
important property of this system. This type of spatiotemporal synchronization is found 
mostly between neuronal networks in more primitive areas of the CNS including, the 
spinal cord and brainstem (S. T. Alford & Alpert, 2014; Cherniak, Etlin, Strauss, 
Anglister, & Lev-Tov, 2014b). Due to their intrinsic property to produce rhythmic 
activity, these neuronal networks are known as central pattern generators 
(CPGs)(Buchanan & Cohen, 1982). 
CPGs for locomotion are one of the most established circuits of the human body. They 
are located in the ventral horn of the lumbosacral spinal cord and have a very high level 
of automaticity (Grillner, 1985; Kiehn, 2006).  
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In a successful gait cycle, while the muscles of one side of a body segment are 
contracted, the muscles of the other side are relaxed. Glutamatergic excitatory neurons of 
the ventral horn of the spinal cord play an important role in producing this pattern 
(Buchanan & Cohen, 1982; Kiehn, 2006). These glutamatergic neurons innervate alpha 
motoneurons bilaterally and inhibitory interneurons of the ipsilateral side, which in turn 
send axons to the opposite side of the spinal cord and innervate the contralateral alpha 
motor neurons. As a result, when glutamatergic interneurons become activated, they 
excite both the motor neurons and ipsilateral inhibitory interneurons, innervating the 
motor neurons of the opposite site. This leads to the excitation of the ipsilateral 
motoneurons, and inhibition of contralateral motoneurons (S. T. Alford & Alpert, 2014; 
S. Alford & Williams, 1989).  
Automaticity is another essential property of the neurons in CPGs circuits (S. T. Alford & 
Alpert, 2014). Studies have shown that the presence of a gradient for the level of 
automaticity between upper and lower lumbar areas. This indicates that upper areas of the  
lumbar spinal cord reproduce more automaticity compared to that of the lower areas  
(Berkowitz, 2004). 
 In a recent study, optogenetic methods were employed in mice to specifically stimulate 
glutamatergic neurons in CPGs. The results indicated that stimulation of these neurons 
alone is enough to initiate and maintain perfect gait cycles in mice. In fact, these 
networks of neurons are able to keep their rhythmic activity without any input from the 
brainstem or sensory feedback from supra-spinal areas in CNS (Hägglund, Borgius, 
Dougherty, & Kiehn, 2010). Constant exposure of these neurons to an NMDA receptor 
agonist does not change their rhythmic activity. This phenomenon can be explained by 
numerous inhibitory interneurons inside the network (Wallén & Grillner, 1987). In 
addition, NMDA receptors on excitatory neurons in CPGs are Ca
2+
 dependent K
+
 
receptors (Buchanan & Cohen, 1982). This means that a single neuron becomes activated 
when glutamate binds to its receptor, but a calcium influx will eventually cause opening 
of potassium channels, resulting in hyperpolarization of the cell (Hill, Matsushima, 
Schotland, & Grillner, 1992). Therefore, even when neurons are exposed to Tetrodotoxin 
(TTX), which prevents the synaptic communication between neurons, NMDA receptors 
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are able to induce rhythmic activity in excitatory neurons of CPGs (Wallén & Grillner, 
1987). These findings suggest that automaticity is an intrinsic characteristic of CPG 
neurons and is not dependent on inputs from supra-spinal areas of the CNS (Buchanan & 
Cohen, 1982; Buchanan & Grillner, 1987; Wallén & Grillner, 1987). An interesting fact 
about the gait CPGs is that gait pattern can be changed without altering speed. This can 
be explained by the existence of different types of neurons inside the CPGs, which each 
control a different aspect of gait (Wilson et al., 2005). 
The central nervous system receives many extrinsic and intrinsic sensorimotor stimuli 
continuously, but the brain’s resources for responding to these stimuli are very limited. 
To overcome this problem, highly specialized structures, such as the basal ganglia and 
many other neuronal networks in the brainstem have developed during 
evolution(Stephenson-Jones, Samuelsson, Ericsson, Robertson, & Grillner, 2011). These 
structures are responsible for identifying the salient stimuli and providing an appropriate 
motor response through activation of relevant CPGs (Redgrave, Prescott, & Gurney, 
1999; Stephenson-Jones et al., 2011). 
In primitive animals such as invertebrates, the amount of incoming sensory information 
and number of motor responses are very limited. As a consequence, the networks 
controlling CPGs in these animals are significantly simpler compared to those of complex 
animals including mammals (Cherniak, Etlin, Strauss, Anglister, & Lev-Tov, 2014a).  
Moreover, the upper brain regions regulating CPGs are also able to control the different 
aspects of gait. For instance, studies on lampreys suggest that the MLR is able to initiate 
locomotion by stimulating locomotion CPGs in the ventral lumbar spinal cord. The MLR 
is also able to control the speed of locomotion and muscle tone by sending commands to 
locomotion CPGs (Smetana et al., 2010).  
Gait is a very complex behavior in mammals and as a result, many neurotransmitters and 
brain areas may control CPGs and motoneurons. To understand the gait mechanism, 
learning about these neurotransmitters and supra-spinal centers is essential. Here we will 
discuss the role of the most important neurotransmitters and anatomical areas involved in 
controlling different aspects of CPGs’ function.  
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1.2 « Raphe Nuclei and Serotonergic System» 
Many studies suggest that serotonergic neurons play an essential role in controlling CPGs 
in both invertebrates and vertebrates (Ghosh & Pearse, 2015; Veasey, Fornal, Metzler, & 
Jacobs, 1995b). The mollusk is an invertebrate that diverged about 600 million years ago; 
but their serotonergic system retains many similarities with vertebrates (Gillette, 2006). 
5-Hydroxytryptamine (5-HT) neurons in these invertebrates are located in three main 
motor CPGs, including the feeding, escape, and locomotion networks. The main role of 
the serotonergic system in these three networks is the excitation of neurons, which leads 
to activation of the CPGs. The serotonergic system is also important in controlling 
different aspects of CPGs function such as, the footfall pattern in rodents (Gillette, 2006).  
In general, the serotonergic system in both invertebrates and vertebrates facilitates the 
spinal reflexes (Kiehn, 2006), but there are some key anatomical and physiological 
differences across species. 
One of the main differences in the serotonergic system of invertebrates and vertebrates is 
the location of the neurons. As mentioned above, in invertebrates, serotonergic neurons 
are located next to the motor CPG networks; however in all vertebrates (from lampreys to 
mammals), most of the serotonergic neurons are concentrated in the raphe nuclei in the 
midbrain (Barreiro-Iglesias et al., 2008). These 5-HT neurons mainly project to motor 
nuclei in the brainstem and motor CPGs in the spinal cord (Veasey, Fornal, Metzler, & 
Jacobs, 1995a). Electrophysiological studies show that these neurons increase their 
activity during spontaneous behaviors like locomotion, feeding, and increased respiratory 
tone following hypercapnia (Aghajanian & Vandermaelen, 1982; Veasey et al., 1995b). 
In addition, there are strong inhibitory interconnections between different raphe nuclei 
and even intrinsically within each of these nuclei. It is proposed that these inhibitory 
interconnections are able to inhibit the activity of inappropriate CPGs and enhance the 
activity of the relevant CPGs (Gillette, 2006). Interestingly, in almost all vertebrates, 
projections of serotonergic neurons from the hindbrain to motoneurons in the spinal cord 
happen at a very early stage of embryogenesis. This emphasizes the importance of this 
system in controlling locomotion (Barreiro-Iglesias et al., 2008). 
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Serotonergic neurons of the raphe nuclei demonstrate specific patterns of electrical 
activity, which allows them to efficiently control CPGs. 5-HT neurons in the raphe nuclei 
have a rhythmic pattern of activity. In these neurons, action potential duration is equal to 
or more than 2 milliseconds, followed by a significant stage of after hyperpolarization 
(Aghajanian & Vandermaelen, 1982; Miguelez, Grandoso, & Ugedo, 2011). In addition, 
these neurons show significant reduction in their activity during sleep, specifically in the 
period of REM. (Urbain, Creamer, & Debonnel, 2006). This reduction in activity during 
sleep can be explained by increased production of melanin concentrating hormone 
(MCH) and decreased level of orexin during sleep and specifically during REM. Both 
MCH and orexin are secreted from the respective populations of neurons in the lateral 
hypothalamus and it is proposed that they are important in controlling different aspects of 
the sleep-awake cycle (Veasey et al., 1995a).  
 
After complete spinal cord transection, invertebrates and primitive vertebrates such as 
lampreys, recover from paralysis and are capable of moving normally again after a few 
months (Chiasson, Baker, & Croll, 1994; Cornide-Petronio, Ruiz, Barreiro-Iglesias, & 
Rodicio, 2011; Koert et al., 2001). Cornide-Petronio ME et al, (Cornide-Petronio et al., 
2011), showed that spontaneous regeneration of serotonergic descending projections are 
mainly responsible for recovery of locomotion in lampreys. Using immunohistochemistry 
methods, these authors have demonstrated that axons from serotonergic neurons in the 
rhombencephalon or dorsal raphe regenerate to the levels below the transection.  
Since CPGs are mainly controlled by the serotonergic system in more primitive animals 
like lampreys, regeneration of serotonergic neurons is enough to recover locomotion. 
However, in more complex vertebrates including mammals, the motor cortex and basal 
ganglia also send projections to the spinal cord through the corticospinal tract, which 
controls the voluntary aspect of locomotion (Murray et al., 2010). 
Murray et al., (Murray et al., 2010) have also discovered that changes in post 
transcriptional editing of 5HT2c receptor mRNA causes an over expression of new 
receptor isoform on motoneurons after spinal cord injury. This isoform for 5HT2c 
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receptor is able to become activated in the absence of serotonin neurotransmitters in the 
spinal cord. This compensatory mechanism helps the motoneurons to regain their 
excitability, which leads to sustained muscle contractions. However, due to the lack of 
the regulatory commands from the brain, the rats developed muscle spasms for a few 
days after the spinal cord injury. 
In conclusion, the serotonergic system is responsible for turning the locomotion CPGs on 
or off, however regulatory effect of other tracts such as reticulospinal tract, and 
corticospinal tract from the supra-spinal areas is required for a successful goal-oriented 
locomotion. 
1.3 « Mesencephalic Locomotor Region » 
Fifty years ago, Shik and colleagues identified the MLR for the first time. In a fascinating 
experiment, they demonstrated that electrical stimulation of a small region in the dorsal 
area of the mesopontine junction in unconscious decerebrated cats induced walking, 
running, and even galloping depending on the frequency of stimulation (Shik, Severin, & 
Orlovskiĭ, 1966). These findings in cats and similar findings in different species, such as 
rodents and salamanders, suggest that the MLR is the gait initiation center (Cabelguen, 
Bourcier-Lucas, & Dubuc, 2003; Skinner & Garcia-Rill, 1984).  The MLR is part of the 
reticular formation in the mesopontine junction and includes the cuneiform nucleus and 
pedunculopontine tegmental nucleus (PPN) (Child & Benarroch, 2013). There are 
numerous studies on the PPN and much research focuses specifically on the cholinergic 
neurons of the PPN. These studies were designed to show the role of these neurons in gait 
(Gut & Winn, 2015). However, the role of the cholinergic neurons in gait remains 
controversial and in fact, many of these studies suggested that PPN cholinergic neurons 
have no effect or a very minor effect on gait (Gut & Winn, 2015; Hernández-Chan et al., 
2011). In addition, PPN electrical stimulation in Parkinson disease patients suffering 
from axial  symptoms and freezing of gait were mostly unsuccessful (Ferraye et al., 
2010). 
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More recent studies suggest a potential role of the PPN in gait because of its essential role 
in integration of sensory information. For instance MacLaren et al., showed that the PPN 
is not important in fixed gait speed and gait initiation in rats (MacLaren, Santini, Russell, 
Markovic, & Clark, 2014). However, in accelerated rotarod studies, bilateral PPN 
cholinergic neuronal loss resulted in severely impaired gait. Gait on a fixed speed rotarod 
is considered an automatic and reflexive behavior. However, maintaining successful gait 
on an accelerated speed rotarod requires the motor system to continuously adjust to 
changes from incoming sensory inputs. The PPN receives fast sensory input and sends 
projections to the substantia nigra pars compacta. These projections contain information 
about the value and salience of the sensory information (Hong & Hikosaka, 2014). 
Contrary to fixed speed performance, in accelerated speed gait, there is a continuous 
change in the sensory information enters the PPN. Therefore, it is proposed that the PPN 
is responsible for integration of sensorimotor information in complex motor tasks (Gut & 
Winn, 2015; Hong & Hikosaka, 2014; MacLaren et al., 2014).  
In addition, two different studies involving single-unit electrode recording from the PPN 
in Parkinson disease patients while they were asked to imagine walking, showed 
significant changes in electrical activity of neurons during gait imagination compared to 
the resting state. These changes suggest that PPN is involved in planning gait (Lau et al., 
2015; Tattersall et al., 2014). 
Therefore, while the PPN and specifically cholinergic neurons of the PPN are one of the 
main suspects in controlling CPGs, well designed studies are needed to prove this claim.   
 
1.4 « Medullary Reticular Formation » 
The medial part of the rostral medulla has been implicated in the modulation of the axial 
motor activity. It is composed of two main parts: the gigantocellular nucleus (GiN) 
located dorsally, and the magnocellular nucleus (MN) located ventrally.  
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The neurons of the GiN send glutamatergic projections down to the spinal cord CPGs via 
the reticulospinal tract (Martin et al., 2011; Vetrivelan, Fuller, Tong, & Lu, 2009). 
It is well known that electrical stimulation of the medial part of the rostral medulla 
suppresses the muscle tone in both decerebrated normal animals during sleep and 
wakefulness (Hajnik, Lai, & Siegel, 2000; Karlsson & Blumberg, 2005; Lai, Kodama, 
Schenkel, & Siegel, 2010). In addition, cell body specific lesions of the glutamatergic 
neurons in this area induces increased muscle tone and phasic muscle activity during both 
REM and non-REM sleep (Vetrivelan et al., 2009) .  
It is believed that the MLR controls the CPGs in the spinal cord through the 
reticulospinal tract.  The MLR sends bilateral and symmetric cholinergic projections to 
the medulla, (Le Ray et al., 2003) (Rolland, Karachi, Muriel, Hirsch, & François, 2011) 
and GiN in the medulla sends projections to the spinal cord CPGs via the RET. However, 
it is not clear whether medullary neurons receive afferent projections from MLR do send 
projections down to the spinal cord.  Recent study by Sherman et al. (Sherman et al., 
2015) identified that MLR neurons send projections directly down to the CPGs in the 
spinal cord. They also found that these neurons are not cholinergic neurons of the 
pedunculopontine nucleus, but they are the fast spiking glutamatergic neurons located 
anterior and posterior to the PPN. 
In order to achieve successful goal oriented locomotion, appropriate body orientation and 
posture is also needed. Studies have shown that the vestibular system in the medullary 
reticular formation controls head orientation and balance by modulating the activity of 
the reticulospinal pathway (Kolkman, Moghadam, & du Lac, 2011). 
In conclusion, while there is no doubt that GiN glutamatergic neurons are important in 
controlling muscle tone during both wakefulness and sleep, there is a big gap in our 
knowledge about the brainstem areas controlling the RET and specifically the GiN in the 
rostral medulla. Our aim from the review in this section is to: 
a) Delineate the pathways controlling the RET and to determine their importance in 
gait.  
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b) Address these questions, by first performing tracer studies to locate the pathways.  
c) Then by pharmacological studies, manipulate these pathways in rats and  
d) Study their gait using the Catwalk XT apparatus. 
Next, different methods for the rats’ gait assessment will be discussed and the advantage 
of using the Catwalk apparatus over other methods will be explained. 
 
1.5 « Methods for Gait Analysis in Rodents » 
There are many available tests to analyze gait and locomotion in animals. The open field 
measurement testing is commonly used by researchers to observe spontaneous 
locomotion of an animal in an open field. This test is developed to measure general 
locomotor activity and exploratory behavior in rodents. However, this test does not 
provide detailed information about different phases of a gait cycle including stance phase 
duration, swing phase duration, stride length, the intensity at which each paw contacts the 
ground, and many other parameters (Mendes et al., 2015).   
Another method commonly used to assess gait and locomotion is foot print analysis. In 
this method, the paws of animals are dipped in ink and then the animals walk across a 
strip of paper. This technique provides information regarding print area (length and 
width) and stride length, but it is very difficult or even impossible to measure other 
parameters of gait including the duration of each phase of the gait cycle or the footprint 
intensity. In addition, controlling animals to walk on papers for several times is time 
consuming and difficult (Neckel, 2015).   
Catwalk XT is an automated gait analysis system, which consists of a long and enclosed 
walkway with a glass plate floor (100* 12* 0.6 cm). It is designed to allow animals 
traverse from one side of the walkway to the other freely with their natural speed. A 
green light is illuminated to the glass plate and while the animals’ paws contact the glass, 
the light becomes scattered. This scattering of light by the animals’ contacts is captured 
by a high speed color video camera mounted below the glass. Then, the recorded videos 
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are transformed into a series of digital images whereby each image is composed of 
numerous pixels. Each pixel contains information about the brightness of the image at a 
very small point and therefore reflects the intensity by which the animal’s paw touched 
the glass plate at that point.  As a result, this device is capable of measuring many 
indices, and several studies have suggested that Catwalk testing provides valid data about 
gait in animal models of spinal cord injury and neurodegenerative disorders as well as 
Parkinson disease (Chuang et al., 2010; Vandeputte et al., 2010; Zhou et al., 2015). The 
following tables (Table 1, and 2) summarize and define the static and dynamic gait 
parameters that were analyzed in our study.  
 
Table2. Static Gait Parameters and Their Definition 
Static Gait Parameters Definition 
Max Contact Area (cm²) Maximum area of a paw that comes into contact with the glass plate. 
Print Area (cm²) The surface area of the complete print. 
Mean Intensity The mean pressure the animal applies with each paw on the glass. 
 
 
 
Table3. Dynamic Gait Parameters and Their Definition 
Dynamic Gait Parameters Definition 
Stand (s) The duration in seconds of a contact of a paw to the glass plate. 
Swing (s) 
 
The duration in seconds of no contact of a paw with the glass plate. 
Swing Speed (m/s) 
 
The speed (Distance Unit/second) of the paw during Swing. 
Stride Length (cm) 
 
The distance (in Distance Units) between successive placements 
 of the same paw. 
Step Cycle(s) 
 
The duration in seconds of stand + swing. 
Duty Cycle (%) 
 
Expressed Stand as a percentage of Step Cycle. 
Body Speed (m/s) 
 
The distance from one initial contact of one paw to the next by the 
 time to travel that distance. 
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Body Speed Variation (%) 
 
Dividing the absolute difference between the Body speed and the 
 Average Speed of a run by the Average Speed. 
Stand Index 
  
A measure for the speed at which the paw loses contact with the glass plate. 
 
 
 
 
 
1.6 « Hypotheses and objectives of This Study » 
The reticulospinal pathway is a phylogenetically old descending pathway, which mainly 
controls the locomotion CPGs and motoneurons of axial and proximal muscles. It is 
believed that this pathway is responsible for automatic and spontaneous control of 
locomotion and body posture (Isa, Kinoshita, & Nishimura, 2013). However, pathways 
and types of neurons and neurotransmitters involved in controlling the glutamatergic 
neurons of this pathway are unknown. The main goal of this study is to investigate the 
area(s) of the brain controlling reticulospinal tract neurons and determining their role in 
gait. Based on the information we discussed above, we hypothesized that: 
 
A) Either or both of DRN and MLR are sending axons to GiN to control reticulospinal 
tract. 
B) Since GiN controls muscle tone, the same region of the GiN controlling the 
reticulospinal tract also controls muscle tone.  
The objectives in this study are summarized here. 
1. Identify brainstem area(s) controlling the reticulospinal pathway. This will be 
discussed in detail in chapter 2. 
2. Determine the importance of the region controlling the reticulospinal pathway in 
gait. This part will be discussed in chapter 3. 
13 
 
3. Identify neurotransmitters and receptor types controlling the reticulospinal 
pathway at the rostral RF using both gait studies and immunohistochemistry. It 
will be discussed in detail in chapter 4. 
4. Determine whether DRN is important in controlling the MLR through gait studies 
and immunohistochemistry. This will be discussed in detail in chapter 5.  
5. Identify if 5HT1A autoreceptors on DRN serotonergic neurons are important in 
controlling gait through gait studies and immunohistochemistry. This part will be 
discussed in chapter 6. 
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Chapter 2  
2       « Identifying the pathways controlling the reticulospinal tract using neural 
retrograde tracer Cholera Toxin Beta Subunit » 
2.1 « Introduction » 
Motoneurons in the spinal cord are controlled by two main groups of pathways: 1) the 
corticospinal tract for fine motor tasks and 2) the reticulospinal tract for gross tasks 
including locomotion, reaching, and posture (Baker, 2011a; Holstege & Kuypers, 1987). 
In other words, in the corticospinal pathway, different combinations of neural activity in 
the motor cortex leads to fine independent finger movements, while the reticulospinal 
pathway controls more axial muscles to maintain posture and balance during locomotion 
(Holstege & Kuypers, 1987; Lawrence & Kuypers, 1968). 
 
The medial part of the rostral medulla has been implicated in the modulation of axial 
motor activity. It is composed of two main parts: 1) GiN located dorsally and 2) 
magnocellular nucleus (MN) located ventrally (Lawrence & Kuypers, 1968). Electrical 
stimulation of the medial part of the rostral medulla suppresses the muscle tone in both 
decerebrated and intact animals during sleep and wakefulness (Hajnik et al., 2000; Lai et 
al., 2010; Vetrivelan et al., 2009). 
 
It is believed that the MLR controls spinal cord CPGs through the RET. The MLR sends 
bilateral and symmetric cholinergic projections down to the medulla in sea lampreys, 
(Rolland et al., 2011) and the GiN in the medulla sends projections down to the spinal 
CPGs via the reticulospinal tract (Martin et al., 2011). However, there is no study 
showing that the neurons in the medulla which receive the projections from MLR are the 
same ones projecting to the spinal cord. A recent study by Sherman et al. identified that 
MLR neurons send projections directly down to the CPGs in the spinal cord. They also 
found that these neurons are not cholinergic neurons of the pedunculopontine nucleus, 
but they are fast spiking glutamatergic neurons located anteriorly and posteriorly to the 
PPN. In addition, MLR neurons are not the only brainstem neurons controlling CPGs in 
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the lumbar spinal cord. Many different types of neurotransmitters including different 
subtypes of serotonergic receptors are identified on the surface of motoneurons (Ghosh & 
Pearse, 2015; Noga, Johnson, Riesgo, & Pinzon, 2009). The serotonergic projections 
arise mainly from the DRN(Barreiro-Iglesias et al., 2008), therefore other mesopontine 
areas other than the MLR might also be important in controlling gait. 
 
In this study, our first goal was to identify groups of neurons controlling the RET with 
the use of a retrograde tracer, Cholera Toxin Beta subunit (CTB). 
 
2.2 « Materials and Methods » 
 
All animal procedures were approved by Animal Care and Veterinary services (ACVS) at 
Western University, London, Ontario, Canada. Five male Sprague-Dawley rats 
weighing 350-400 grams were used for the first part of the tracer study. Rats were 
walled cages after the surgery with free access to -Plexiglasindividually housed in 
-light at 22±1 ºC on a 12 hourwas kept  temperature of the roomfood and water. The 
PM). cycle (lights on from 7 AM to 7-dark 
 
Surgical Procedure 
For the first series of experiments, retrograde tracer Cholera Toxin beta subunit (CTB) 
The animals were was microinjected in the ventral horn of the lumbar spinal cord. 
chloride (Vetalar, initial dose 80 mg/kg and droyanaesthetized with ketamine h
sthetized rats were eAna). ine (0.8 mg/kg,zand xyla ,)/kgmaintenance dose 40 mg
(Kopf Instruments,  placed on a Kopf stereotaxic frame with spinal attachment
Tajunga, CA). 
The retrograde tracer, Cholera Toxin Subunit ß (CTB) (Life Technologies) conjugated 
with Alexa Fluor 594, was microinjected (0.5 µl of 1.0 mg/ml solution per site) in to the 
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ventral horn of the lumbar spinal cord in 5 rats, using 10µl Hamilton syringe, mounted 
and held by a Kopf Micro injector. To inject in the ventral horn of the lumbar spinal 
(L2/3) cord, a small hole was drilled in the lamina close to the spinous process. Dura was 
split to expose spinal cord.  The syringe needle was lowered through the hole and spinal 
cord vertically until it reached the stereotactic targets at the ventral horn of the spinal 
cord, and the tracer was slowly injected over 3 minutes. After the injection, the needle 
was kept in place for an additional 3 minutes.  Surgical wound was closed with nylon and 
skin clips. The rats were sacrificed 4 days after the surgery. 
 
In another group of 10 rats weighting 250-270 grams, 0.5µl of 1 mg/ml CTB solution was 
microinjected in the medial part of the rostral medulla using stereotaxic coordinates for 
the GiN (AP= ˗11.0, M=0, DV= ˗9.0; Paxinos and Watson, 2007). These rats were 
sacrificed 48 hours after surgery. 
 
Histology 
After completion of experiments, animals received an overdose of sodium pentobarbital 
and were perfused transcardially with 0.9% NaCl containing 1 ml/lit heparin followed by 
4% formaldehyde solution (in 0.05 M PB). The brains and spinal cords were removed 
and kept in 4% formaldehyde solution for 48 hours and then 26% sucrose solution in PB 
until they sink. Coronal sections (40 µm) through the entire length of the brainstem were 
cut using a freezing sliding microtome. Every fifth section was mounted and the sections 
were examined using Olympus FV1000 confocal microscope, and representative images 
were digitally recorded. 
 
2.3 « Results » 
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CPGs are mainly controlled by three areas in the brainstem 
A representative injection site is shown in figure 1. Based on previous studies, we 
predicted that the CPGs in the ventral part of the spinal cord receive projections from two 
main areas: 1) The medial zone of the rostral reticular formation where the GiN is located 
and 2) The DRN (Fig2A, B). In addition to these two locations, we also found that CPGs 
are also receiving direct projections from the MLR which is known as an important 
center for gait initiation (Fig2c).  
 
 
 
 
Figure1. CTB injection site at the 
ventral horn of the lumbar spinal 
cord.  
Upper image shows the CTB 
injection site at the ventral horn of 
the lumbar spinal cord (white 
arrow). 
Lower image shows a section of the 
ventral horn of the lumbar spinal 
cord rostral to the injection site.  
 
1mm 
0.2mm 
 0.1mm 
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Figure2. Neurons in three areas of the brain stem picked up the CTB 
tracer GiN (A), DRN (B), and MLR (C). Scale bars = 50µm 
A 
B 
C 
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The reticulospinal tract receives strong projections from the DRN and not the MLR 
In contrast to a general consensus regarding the control of the reticulospinal tract by 
cholinergic neurons in the MLR, we found that the DRN sends projections down to 
the GiN (Fig3). In addition, we examined many sections under the microscope to 
find the neurons in the MLR area which would send projections down to the rostral 
reticular formation. However, we did not see any labeling in that area. 
 
 
 
C 
B 
A 
Figure3. CTB Injection Site at GiN. Injection site is presented at GiN (white arrow) (A). 
Neurons at DRN picked up the tracer: (B) shows 10 ˟ magnification, and (C) shows 40 ˟ 
magnification. Scale bars = 50µm 
Aqueduct 
Aqueduct 
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2.4 « Discussion » 
In the present study, we injected the neural retrograde tracer CTB at the ventral horn of 
the lumbar spinal cord, where motoneurons and CPGs are located. Three main 
locomotion related areas in the brainstem were labeled for the tracer: DRN, MLR, 
and GiN. In a separate series of rats, we injected CTB in to the GiN. DRN neurons 
were labeled by CTB, but there was no signal for the tracer in areas anterolateral to 
the DRN where the MLR and PPN are located. In other words, we found evidence 
for three parallel pathways from the brainstem to the motoneurons and CPGs inside 
the spinal cord. The first pathway originates from the DRN directly, the second 
pathway is coming indirectly from the DRN through the GiN, and the third pathway 
arises from the MLR directly (Figure 2, and 3). 
It is well known that many descending pathways including the corticospinal tract, 
vestibulospinal tract, and rubrospinal tract also project to the ventral horn of the 
spinal cord where lower motoneurons and CPGs are located (Isa et al., 2013), in the 
current study, while the tracer might also be found in other brain areas besides the 
MLR, DRN, and the GiN, we only focused on the brain stem structures which are 
proposed to have a role in controlling the reticulospinal tract. 
The direct pathway from the DRN to CPGs is very well known, and spinal cord injury 
studies have shown that loss of serotonergic innervation in this pathway caused 
severe impairment in gait in almost all species(Courtine et al., 2009). On the other 
hand, stimulation of motoneurons by serotonin facilitates the gait and locomotion 
cycle which emphasizes the role of  the DRN direct pathway in controlling 
motoneurons (Ghosh & Pearse, 2015; Noga et al., 2009; Veasey et al., 1995b). 
Our findings on the other two pathways are against the prior literature about the MLR 
and PPN, which suggested that these areas are the main structures sending 
projections down to the GiN (Rye, Lee, Saper, & Wainer, 1988; Skinner & Garcia-
Rill, 1984).  In agreement with this, a recent study by Sherman et al. showed that the 
MLR in the mesopontine junction does not send projections to the medullary 
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reticular formation, rather does send direct projections down to the spinal cord 
motoneurons. 
 While prior studies have shown that PPN cholinergic neurons are sending projections 
down to the GiN, there are several recent studies suggesting that cholinergic neurons 
in the PPN mostly send projections to the ventrolateral thalamic nucleus, and dorsal 
striatum (Dautan et al., 2014; Wen et al., 2015).   
Our current knowledge about the role of the MLR and PPN in gait stems mainly from 
electrical stimulation studies. Since cholinergic neurons in the PPN send projections 
up to the dorsal striatum and ventrolateral thalamic nucleus, the two subcortical 
structures which are important in motor function, it is difficult to interpret the effect 
of PPN stimulation on efferent pathways to the spinal cord, such as the RET. In 
recent studies, low frequency stimulation of the PPN has been shown to produce 
changes in neural activity in the ventrolateral thalamus, substantia nigra pars 
reticulata, and sub thalamic nucleus (Park, Song, Jang, & Kim, 2014; Wen et al., 
2015). These three areas are affected in Parkinson disease and the studies suggested 
that the therapeutic effect of PPN stimulation on gait and posture might stem from 
the improvement in activity of these pathways.  
On the other hand, deep brain stimulation of the PPN in PD patients does not always 
show satisfactory outcome, and many animal and human studies suggest that PPN 
stimulation is not improving gait and posture (Ferraye et al., 2010; Gut & Winn, 
2015). In addition, studies have shown that the best area for deep brain stimulation is 
posterior or even outside of the PPN (Ferraye et al., 2010; Gut & Winn, 2015; 
Zrinzo, Zrinzo, & Hariz, 2007). Since the DRN is adjacent to the posterior part of 
the PPN, it is possible that by stimulation of this area, neural activities of the DRN 
neurons are also modified. This could be one of the mechanisms of gait 
improvement during stimulation of the posterior PPN. 
In conclusion, tracer studies have shown that DRN is sending projections to both the GiN 
and motor neurons in the lumbar spinal cord. These findings imply that in addition 
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to the MLR, the DRN may also plays an important role in controlling gait and 
posture. 
23 
 
Chapter 3  
3 «               3   « Role of the Dorsal Raphe Nucleus in Gait. » 
 
3.1 « Introduction » 
In the first part of the study, we showed that serotonergic neurons of the DRN send 
strong projections down to the GiN neurons of the medial part of the rostral reticular 
formation. 
Serotonergic neurons in the raphe nuclei in most species have a spontaneous rhythmic 
activity. This pacemaker property is caused by intrinsic and gradual depolarizing ramps 
observed in these neurons. This gradual depolarization results in an action potential 
duration of 2 or more milliseconds, followed by a significant stage of after 
hyperpolarization (Aghajanian & Vandermaelen, 1982; Urbain et al., 2006). Another 
interesting property of these 5-HT neurons is their rate of firing during different states of 
activity. Most of these neurons have the high rate of tonic activity during wakefulness 
and show significant reduction in their activity during sleep. In fact, they are completely 
silent during REM sleep, when the voluntary muscles are paralyzed (Urbain et al., 2006). 
These properties make DRN serotonergic neurons good candidates for controlling 
locomotion related CPG neurons in the lumbar spinal cord. Many studies suggest that 
serotonergic projections to the motoneurons and CPGs play an essential role in 
controlling CPGs and making gait patterns in both invertebrates and vertebrates(Kiehn, 
2006). These studies employed electrophysiological recording during pharmacological 
manipulation of motoneurons in in vitro slices of the spinal cord (Gackière & Vinay, 
2014).  
To the best of our knowledge, there are no studies analyzing gait parameters after 
inhibition of the DRN nucleus in vivo in awake behaving animals. In this part of the 
study, we inactivated DRN neurons by lidocaine and then analyzed the gait pattern while 
the rats were spontaneously walking on Catwalk. It was hypothesized that inactivation of 
24 
 
DRN projections to the motoneurons will result in abnormal foot fall pattern and 
abnormal coordination between limbs. 
 
3.2 « Material and Methods » 
Six male Sprague-Dawley rats (10-12 weeks old), weighing 250-270 grams were used. 
Plexiglas cages, with free access to food and water. Rats were individually housed in 
cycle (lights on  dark-The room temperature was kept at 22±1 ºC on a 12 hour light
).:00 pmto 7 am :00from 7 
 
Surgical Procedures 
chloride (Vetalar, initial dose 80 mg/kg droyhtized with ketamine nimals were anaestheA
Anesthetized  ).i.m.ine (0.8 mg/kg, and xylaz )i.m., 40 mg/kg and maintenance dose
stereotaxic frame (Kopf Instruments, Tajunga, CA) and the incisor rats were fixed in 
bar was adjusted until the anterior and posterior parts of skull were horizontal. 
Stereotaxic coordinates of Paxinos and Watson atlas (2007) were used and the 
reference point was bregma. Indwelling stainless steel 27-g guide cannulae were 
implanted 1.5 mm above the posterior border of the DRN. The coordinates are in 
millimeters: AP= ˗8.3, M=0, DV= ˗6.4 for DRN. Following surgery, rats were 
allowed to recover in their home cages for a period of 7 days. 
 
Gait Studies 
 
Gait parameters were measured using Catwalk XT (Noldus). While the animals are 
traversing the walkway with their natural speed, a green light illuminates the glass plate 
on the floor of the walkway. The light becomes scattered when the animals’ paws contact 
the glass, and this will be recorded by a high-speed camera mounted below the glass. The 
glass dimension is 100 cm length x 12 cm width x 0.6 cm thickness, which lets the 
animals to complete at least 7 step cycles by walking up to 70 cm of the length. The 
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definition of the gait parameters we measured in this study are summarized on Tables 3 
and 4. 
One day prior to the above surgical procedure, all rats underwent Catwalk training to 
familiarize them to the walkway and to ensure their ability in conducting successful gait 
trails.  
 
Table3. Static Gait Parameters and Their Definition 
Static Gait Parameters Definition 
Max Contact Area (cm²) Maximum area of a paw that comes into contact with the glass plate. 
Print Area (cm²) The surface area of the complete print. 
Mean Intensity The mean pressure the animal applies with each paw on the glass. 
 
Table4. Dynamic Gait Parameters and Their Definition 
Dynamic Gait Parameters Definition 
Stand (s) The duration in seconds of a contact of a paw to the glass plate. 
Swing (s) 
 
The duration in seconds of no contact of a paw with the glass plate. 
Swing Speed (m/s) 
 
The speed (Distance Unit/second) of the paw during Swing. 
Stride Length (cm) 
 
The distance (in Distance Units) between successive placements 
 of the same paw. 
Step Cycle(s) 
 
The duration in seconds of stand + swing. 
Duty Cycle (%) 
 
Expressed Stand as a percentage of Step Cycle. 
Body Speed (m/s) 
 
The distance from one initial contact of one paw to the next by the 
 time to travel that distance. 
Body Speed Variation (%) 
 
Dividing the absolute difference between the Body speed and the 
 Average Speed of a run by the Average Speed. 
Stand Index 
  
A measure for the speed at which the paw loses contact with the glass plate. 
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At the first day of the experiment, a tight-fitting 30-g injection cannulae were inserted 
into the guide cannula in such a way that protruded 1.5 mm from the tip of the guide 
cannulae to reach the DV coordinates of the DRN. All Infusions were carried out over 1 
minute and the injection cannulae were kept in place for an additional 60 seconds to 
minimize back flow of the solution. 
First, 0.5µl of sterile 0.9% saline was injected in DRN. Five minutes after the injection 
the animals were placed on catwalk walkway, where they were able to walk freely with 
their normal pace. For each vehicle or drug injection for each animal, three successful 
gait trials were recorded. A successful gait trial is when the animal starts walking from 
one side of the glass plate and finishes its gait to the other side of the glass without 
turning back.  
An hour after the saline injection, 0.5µl of sterile lidocaine hydrochloride 4% (Lidodan 
4%) was injected in the DRN (Prado & Faganello, 2000), and five minutes after the 
injection the rats were placed on catwalk and their gait was measured. 
In the second day of the experiment, the same steps were repeated with administration of 
1µl of lidocaine 4% in the DRN. 
To verify the placement of the cannulae, 0.5µl of a 4% methylene blue solution was 
infused in the DRN and the extent of the dye spread after half an hour was considered as 
an indication of the presumed diffusion of the normal saline or Lidocaine which was 
given to each animal during the experiments.  
 
Statistical Analysis  
 In this study, gait parameters of six animals in each group were measured, similar studies 
on Catwalk apparatus have shown that this number of the subjects provides a valid data 
set (Chuang et al., 2010; Mendes et al., 2015; Vandeputte et al., 2010; Zhou et al., 2015). 
All the recorded videos were double-checked to correct any possible errors that the 
Catwalk software might have made in labeling the paws. All walkway crossings were 
analyzed using the Catwalk software data. Each gait parameter is expressed as mean ± 
S.E.M (Standard error of the mean). SPSS statistical software (version 19) was used to 
analyze all parameters. Statistical significance was evaluated by the Friedman Test and 
group differences were determined by the non-parametric Wilcoxon test. Since the 
27 
 
number of the subjects we used in each group of the animals was small (n=6), 
normalization of the data was not appropriate, therefore, we used Wilcoxon test that does 
not assume normality in the data. In this study, a P value lower than 0.05 was considered 
to be statistically significant. 
 
3.3 « Results » 
Verifying Cannulas Placement 
Six male Sprague-Dawley rats underwent surgery and single cannulae were inserted in 
the cerebral aqueduct adjacent to the posterior border of the DRN. To verify the 
placement of the cannulae, 0.5µl of a 4% methylene blue solution was infused through 
the cannulae and half an hour later animals were sacrificed. Frozen sections through the 
brainstem were Nissl stained and the cannulae placement site was verified under the 
microscope Figure4. 
 
  
1mm 
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Effect of DRN inhibition by 0.5µl Lidocaine 4% on gait: 
The vehicle’s effect on gait was tested by injection of 0.5 µl normal saline in the DRN 
4%  N by 0.5µl Lidocainehibition of DRInand studying the rats’ gait on Catwalk. 
gait parameters significantly. ) (Table 6and dynamic  )(Table 5impaired both static 
rint area in all pmaximum contact area in forelimbs and  ,rametersaAmong static p
limbs are significantly decreased. Although almost all other static parameters 
x are also decreased, the changes are not including maximum intensity and stand inde
).(Table 5statistically significant  
 
 
 
 
 
 
      Static Gait Parameters 
Normal 
Saline   Lidocaine 
  P 
Value 
MaxContactArea (cm²) RF 4.2±0.99 2.99±0.44 0.046 
MaxContactArea (cm²) RH 3.6±1.29 3.1±0.84 0.345 
MaxContactArea (cm²) LF 4±0.78 3.08±0.30 0.046 
MaxContactArea  (cm²) LH 3.96±1.6 3.13±0.89 0.463 
PrintArea (cm²) RF 5.88±1.64 3.7±0.53 0.046 
PrintArea (cm²) RH 4.86±1.68 4.07±0.9 0.028 
PrintArea (cm²)LF 5.9±1.65 3.9±0.36 0.046 
PrintArea (cm²)LH 5.2±1.96 3.9±0.91 0.028 
Max Intensity RF 192.6±17.4 182.6±18.4 0.345 
Max Intensity RH 190±21.6 170±31.4 0.249 
Figure4. Low (A), and high (B) magnification of cannula site at cerebral aqueduct, 
next to the dorsal border of DRN (black arrow) taken from two representative cases. 
Nissl stained sections showing the intended position of the cannula tip. Infusions were 
made just at the dorsal border of the DRN to prevent mechanical damage to the 
nucleus. In some cases, cannula tip has just penetrated the DRN (A). 
Table 5. Static Gait Parameters after Injection of Lidocaine: 
Mean ± standard deviation is measured for each parameter in 
individual limbs. P values<0.05 are considered significant and 
are highlighted with light green color. 
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Max Intensity LF 189.4±11.2 183±21.1 0.345 
Max Intensity LH 179.5±31.2 177±22 0.6 
Mean Intensity RF 71.74±3.6 73.27±6.46 0.463 
Mean Intensity RH 78.3±11.4 74.4±11.9 0.6 
Mean Intensity LF 71.3±5.1 73.6±7.6 0.6 
Mean Intensity LH 78.1±14.2 77.3±13 0.753 
Stand Index RF 4.2±0.75 3.2±0.87 0.075 
Stand Index RH 2.2±0.4 1.5±0.3 0.046 
Stand Index LF 4.4±0.92 3.4±0.82 0.116 
Stand Index LH 2.2±0.44 2.1±0.5 0.463 
 
In addition, most of the time dependent parameters or dynamic parameters significantly 
Each step cycle is made of two parts: stand and swing. The data . )ble 6Ta( changed
in lidocaine  longerwere significantly shows that both of these two parameters 
which suggests the ratio  ,not changedid However, the duty cycle eated rats. tr
. While the rats remain constantin each step cycle  duration between stand and swing
, several episodes of freezing happened during each trial Catwalkwere walking on 
. The freezing episodes are represented as a significant e injectionafter lidocain
increase in body speed variation in all four limbs (p value= 0.028). This variation 
 occurs because a gait freezing episode produces a dramatic reduction in body speed.
Figure5 and 6.this part are also summarized in The key findings in  
  
 
 
 
 
 
 
 
 
 
Table 6. Dynamic Gait Parameters after Injection of Lidocaine: 
Mean ± standard deviation is measured for each parameter in 
individual limbs. P values<0.05 are considered significant and 
are highlighted with light green color. 
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    Dynamic Gait Parameters 
 Normal 
Saline   Lidocaine 
  P 
Value 
Stand (s) RF 0.34±0.06 0.8±0.6 0.046 
Stand (s) RH 0.46±0.09 1.22±1.1 0.028 
Stand (s) LF 0.34±0.08 0.69±0.39 0.046 
Stand (s) LH 0.44±0.12 1.3±0.9 0.028 
Swing (s) RF 0.22±0.04 0.29±0.11 0.046 
Swing (s) RH 0.125±0.02 0.14±0.03 0.028 
Swing (s) LF 0.18±0.05 0.5±0.4 0.046 
Swing (s) LH 0.135±0.04 0.17±0.05 0.028 
Swing Speed (cm/s) RF 94.97±23.4 83.3±24.6 0.345 
Swing Speed (cm/s) RH 130.2±17.1 110.5±31 0.116 
Swing Speed (cm/s) LF 107.67±10.56 109.04±13.3 0.028 
Swing Speed (cm/s) LH 129.07±7.74 149.39±35.9 0.249 
Stride Length (cm) RF 14.28±1.8 12.4±1.3 0.116 
Stride Length (cm) RH 15.6±1.45 13.7±0.9 0.046 
Stride Length (cm) LF 13.2±2.5 13.1±1.4 0.917 
Stride Length (cm)LH 14.9±1.8 13.3±1.8 0.345 
Step Cycle (s)RF 0.59±0.12 1.01±0.4 0.046 
Step Cycle (s) RH 0.6±0.12 1.1±0.6 0.028 
Step Cycle (s) LF 0.53±0.1 1.25±0.9 0.028 
Step Cycle (s)LH 0.6±0.14 1.25±0.7 0.028 
Duty Cycle (%) RF 63.35±4.1 67.45±5.8 0.116 
Duty Cycle (%)RH 74.98±3.89 78.4±3.79 0.075 
Duty Cycle (%)LF 63.6±4.3 65.7±4.6 0.173 
Duty Cycle (%)LH 74.36±3.9 73.4±2.00 0.917 
Body Speed (cm/s) RF 25.4±3.85 19.6±5.88 0.075 
Body Speed (cm/s) RH 26.1±3.8 21.02±4.8 0.028 
Body Speed (cm/s) LF 25.7±3.5 19.65±5.4 0.116 
Body Speed (cm/s) LH 26.6±4.3 20.5±5.4 0.249 
Body Speed Variation (%) RF 41.8±10.4 86.3±30.3 0.028 
Body Speed Variation (%) RH 42.4±13.5 88.6±32.4 0.028 
Body Speed Variation (%) LF 45.1±12.4 81.5±17.8 0.028 
Body Speed Variation (%) LH 41.0±10.3 85.2±28.6 0.028 
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* 
* 
Figure5. Key findings of the performance on the Catwalk for static gait 
parameters after injection of 0.5µl normal saline and after injection of 0.5µl 
Lidocaine 4% in DRN. Graphs show group means ± SEM of selected gait 
parameters. * p<0.05 
* *  *  * 
 * 
* 
 * 
 *   * 
 * 
  * 
 * 
  *  *   *  *  * 
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experiment 1µl of lidocaine was microinjected in DRN. Five One day after the first 
. While the rats were Catwalkon placed minutes after the injection, rats were 
and their reflexes intact, they experienced several episodes of  consciouscompletely 
apparatus was not able to record their gait.  Catwalksevere freezing. Therefore, the 
In very rare experiments that rats were able to walk, their footfall patterns were 
).(Figure 7ally irregular tot 
 
 
 
 
 
 
A 
C 
B 
Figure7. Foot fall pattern after normal saline injection in DRN (A), 0.5µl 
Lidocaine 4% injection in DRN (B), and 1µl Lidocaine 4% injection in DRNN 
(C). One episode of freezing of gait is seen in image B, but the foot fall pattern 
is preserved. Footfall pattern is completely irregular in image C. 
Figure6. Key findings of the performance on the Catwalk for dynamic gait 
parameters after injection of 0.5µl normal saline and after injection of 0.5µl 
Lidocaine 4% in DRN. Graphs show group means ± SEM of selected gait 
parameters. * p<0.05 
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3.4 « Discussion » 
DRN in rats using 0.5 µl of  the und that partial inhibition ofwe fo ,this part of the studyIn 
in significant impairment in static gait parameters including  slidocaine result
int area, as well as many dynamic gait parameters contact area, and pr imummax
including stand, swing, step cycle, and body speed variation. We also injected 1µl of 
gait due their and this time we were not able to record  DRN of ratsthe lidocaine in 
animals. sesevere freezing of gait in the to 
to serotonergic projections from the DRN are among the very first axons  ,In mammals
Iglesias et al., 2008; Vinay et al., -(Barreiroreach the motoneurons in the spinal cord 
s resulted in postural . Reduced 5HT secretion in early days after birth in rodent2002)
asymmetry  and abnormal gait, which implies the importance of 5HT secretion from 
(Pflieger,  of interconnections between CPGs developmentDRN projections in 
5HT2 receptor agonist a . Injection of inay, 2002; Vinay et al., 2002)Clarac, & V
(Brumley, Roberto, & Strain, induced alternating air stepping in intact newborn rats 
in vitro experiments on isolated spinal cord preparations of rats also  , and2012)
that activation of 5HT2 receptors induce normal right/left and  edsuggest
ince these studies . S(Nakayama, Nishimaru, & Kudo, 2002)extensor/flexor pattern 
important role in inter and an all suggest that activation of 5HT receptors are playing 
limb coordination, many studies designed for transplantation of embryonic -intra
nt models and serotonergic neurons under the lesion site in spinal cord injury rode
(Majczyński, surprisingly many of these studies found this treatment effective 
.  Maleszak, Cabaj, & Sławińska, 2005; Sławińska et al., 2013) 
Projection of DRN serotonergic neurons is not confined to motoneurons and CPGs.  
receptors on GABA interneurons and  1AThere are considerable number of 5HT
(Kruglikov & Rudy, 2008; Puig, Artigas, &  of motor cortexlayer V pyramidal cells 
rotoxin was 5,7 DHT neuthe . In a study by Scullion et al., Celada, 2005)
lateral ventricle which resulted in widespread depletion of  microinjected into the
lly in cortex. The rats developed significant forelimb movement serotonin specifica
 1Aated that 5HTimpairment in skilled reaching movements. They also demonstr
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to wild  antly smaller motor maps comparedsignifichad out mice  receptor knock
type mice.  
DRN serotonergic projections to the motoneurons and motor  studies suggest thatThese 
 . However,locomotion animals’us, cortex are essential in limb coordination and th
no study has focused on the effect of direct DRN inhibition in gait parameters.  
e expecting to see significant changes in dynamic Based on the above studies, we wer
we also However, parameters and significant impairment in limb coordination. 
contact area  imumfound that static parameters are also significantly impaired. Max
decreased in all four limbs. While s in forelimbs and print area wawas decreased 
cle tone in limbs, these findings schanges of these two indices are dependent on mu
suggest that DRN neurons are also important in controlling the muscle tone during 
reticular  ryral medullarostthe locomotion. Muscle tone is mainly controlled by 
formation or GiN. Therefore these findings are consistent with the tracer study 
projections to DRN sends the findings in previous chapter, where we showed that 
GiN.the  
GiN by injection  the into manipulate neurons a study To prove this claim, we designed 
of different serotonergic receptors agonists and antagonists, while measuring the rats 
.Catwalkgait on  
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Chapter 4  
4                «Dorsal Raphe Nucleus Controls Reticulospinal Tract Neurons In 
Gigantocellular Nucleus through 5HT1A and 5HT2 receptors. » 
 
4.1 « Introduction » 
Electrical stimulation of the medial part of the rostral medulla suppresses the muscle tone 
in both decerebrated and intact animals during sleep and wakefulness (Hajnik et al., 
here are several studies T.2000; Karlsson & Blumberg, 2005; Lai et al., 2010)
projections down  ucleus neurons sendn igantocellulargsuggesting that the group of 
(Martin et al., ospinal tract are glutamatergic CPGs through the reticul to the spinal
s of these glutamatergic ell body specific lesionC .2011; Vetrivelan et al., 2009)
neurons induces increased muscle tone and phasic muscle activity during both REM 
re is not enough However, the .(Vetrivelan et al., 2009) leepREM s-nonand 
information about the detailed connectivity of these neurons and the type of the 
projections that these glutamatergic neurons are receiving. 
that microinjection of the retrograde neural tracer  it was shownast two chapters, pIn the 
aphe nucleus. rorsal serotonergic neurons of the d of rats labeledthe GiN CTB in 
we  ,, to understand the role of these serotonergic neurons in gaitSubsequently
apparatus. We  Catwalkby to the DRN and studied rats’ gait inidocaine Linjected 
airment in both static and dynamic parameters of gait in found a significant imp
the  ,with higher doses of the Lidocaine (1µl of Lidocaine 4%). Moreover, those rats
and recording their gait was almost impossible.froze rats completely  
subtypes of serotonergic  uncover the were designed tothis study steps of The next 
in  srolespecific  irGiN, and the the receptors controlling reticulospinal neurons in
 .gait 
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Since there are 7 serotonin receptor classes and at least 13 known serotonin receptor 
agonists and  , it was difficult to study(Raymond et al., 2001) brainthe subtypes in 
hich receptors are located identify wto  in order antagonists for all of these receptors
from previous studies,  it is known that two types of However, on GiN neurons. 
receptors are abundantly found on the surface of motoneurons in the spinal cord, 
(Courtine et al., 2009; Ghosh & Pearse,  receptors 2and 5HT 1A5HTthe are which 
. While the ligand (serotonin neurotransmitter) is the same 2015; Murray et al., 2010)
receptors are  2. 5HToppositer activity is completely for these two receptors, thei
 1A5HT ,n contrast. Igait facilitatesexcitatory and their excitation on motoneurons 
 receptors are inhibitory and their activation induces hyperpolarization in neurons
. (Scullion et al., 2013) 
agonists and antagonists  2and 5HT 1AHere we hypothesized that injection of 5HT
.Catwalkively, will change the muscle tone in rats while they are walking on respect 
 
4.2 « Materials and Methods » 
Six male Sprague-Dawley rats (10-12 weeks old), weighing 250-270 grams were used. 
food and water.  Plexiglas cages, with free access toRats were individually housed in 
cycle (lights on  dark-The room temperature was kept at 22±1 ºC on a 12 hour light
).:00 pmto 7 am :00from 7 
Surgical Procedures 
Animals were anaesthetized with ketamine hydrochloride (Vetalar, initial dose 80 mg/kg 
and maintenance dose 40 mg/kg, i.m.) and xylazine (0.8 mg/kg, i.m.). Anesthetized rats 
were fixed in stereotaxic frame (Kopf Instruments, Tajunga, CA) and the incisor bar was 
adjusted until the anterior and posterior parts of skull were horizontal. Stereotaxic 
coordinates of Paxinos and Watson atlas (2007) were used and the reference point was 
bregma. Indwelling stainless steel 27-g guide cannulae were implanted 1.5 mm above the 
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GiN. The coordinates are in millimeters: F= ˗11, L=0, H= ˗9 for GiN. These rats were 
kept in their cages for a 7 days of recovery period. 
Drugs 
8OH-DPAT (8-HYDROXY-2-(DI-n-PROPYLAMINO)TETRALIN) and Ketanserin 
tartrate were purchased from Tocris Cookson (Ellisville, MO, USA). 
Gait Studies 
One day prior to surgery, all rats underwent Catwalk training to familiarize them to the 
walkway and to ensure their ability in conducting successful gait trails.  
Tight fitting 30-g injection cannulae were inserted into the guides. They protruded 1.5 
mm from the guide cannulae to reach the coordinates mentioned above for the GiN. 
Infusions were carried out over 1 minute and the injection cannulae were kept in place for 
another 60 seconds to minimize backflow. 
 
On the first experimental day, 0.5µl of sterile 0.9% saline was injected in the GiN. Five 
minutes after the injection, the animals were placed on the Catwalk apparatus, where they 
were able to walk freely with their normal pace. For each vehicle or drug injection of 
each animal, at least three successful gait trials were recorded. A gait trial is considered 
successful if the animal starts walking from one side of the glass plate and completes its 
gait to the other side of the glass without turning back.  
An hour after the saline injection, 10µM of sterile 8OH-DPAT (Pham-Le, Cockburn, 
Nowell, & Brown, 2011) was injected in the GiN. Five minutes after the injection, the 
rats were placed on Catwalk and their gait was measured. Few days later, the same steps 
were repeated with 0.5µg/0.5µl Ketanserin tartrate, a 5HT2A/2c antagonist (McCool, 
Christian, Fetzer, & Chappell, 2014) instead of 8OH-DPAT. 
Histology 
Upon completion of experiments, animals received an overdose of sodium pentobarbital 
and were perfused transcardially with 0.9% NaCl (containing 1 ml/lit heparin) followed 
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by 4% formaldehyde solution (in 0.1 M phosphate buffer). The brains and spinal cords 
were removed and kept in 4% formaldehyde solution for 48 hours and then 26% glycerol 
solution until they sink. 
To visualize colocalization of the CTB retrograde tracer (from animals in chapter 2, in 
which CTB was microinjected in CPGs) with 5HT1A and 5HT2 in the GiN, 40µm coronal 
sections were cut using a microtome and every fifth section was stained for 5HT1A or 
5HT2 receptors.  
A rabbit anti-5HT1A primary antibody (SR-1A Antibody, Santa Cruz Biotechnology) and 
a Biotinylated Goat Anti-Rabbit IgG secondary antibody (Vector Laboratories) were 
used. The primary antibody for 5HT2 receptors was a goat anti-5HT2 antibody (SR-2c 
Antibody, Santa Cruz Biotechnology) and the secondary antibody was a Biotinylated 
rabbit Anti-Goat IGg Antibody (Vector Laboratories).Then, sections were studied under 
Olympus FV1000 microscope. 
To verify the placement of the cannulae, 1µl of a 4% methylene blue solution was 
infused in the GiN and the extension of the dye after half an hour was considered as an 
indication of the presumed diffusion of the normal saline or the drugs which were given 
to each animal during the experiments.  
Statistical Analysis  
In this study, gait parameters of six animals in each group were measured, similar studies 
on Catwalk apparatus have shown that this number of the subjects provides a valid data 
set (Chuang et al., 2010; Mendes et al., 2015; Vandeputte et al., 2010; Zhou et al., 2015). 
All the recorded videos were double-checked to correct any possible errors that the 
Catwalk software might have made in labeling the paws. All walkway crossings were 
analyzed using the Catwalk software data. Each gait parameter is expressed as mean ± 
S.E.M (Standard error of the mean). SPSS statistical software (version 19) was used to 
analyze all parameters. Statistical significance was evaluated by the  Friedman Test and 
group differences were determined by the non-parametric Wilcoxon test. Since the 
number of the subjects we used in each group of the animals was small (n=6), 
normalization of the data was not appropriate, therefore, we used Wilcoxon test which 
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does not assume normality in the data. In this study, a P value lower than 0.05 was 
considered to be statistically significant. 
 
4.3 « Results » 
Verifying Cannulas Placement 
To verify the placement of the cannulae, 1µl of a 4% methylene blue solution was 
infused through the cannulae and half an hour later animals were sacrificed. Sections 
were prepared and the cannulae sites were verified under the microscope Figure 8. 
 
 
 
Effect of 5HT1A agonist, 8OH-DPAT injection in the GiN on gait. 
After injection of the vehicle (normal saline) the animal’s baseline normal gait was 
recorded on the Catwalk. One hour later, 10 µM of 8OH-DPAT, a 5HT1A agonist (Pham-
Le et al., 2011) was microinjected in the GiN and then the rats were placed on the 
Catwalk again . The findings showed significant decrease in static parameters including 
maximum contact area, print area, and maximum intensity, which suggest that the 5HT1A 
Figure8. Cannula site at GiN (black 
arrow). Methylene blue 4% was 
microinjected through cannulae. After 
making sections Nissl staining with neutral 
red color is done on the sections. 
 
1mm 
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antagonist is affecting the muscle tone of limbs during gait. In contrast to static 
parameters, there was no significant change in any of the dynamic parameters including 
body speed variation (See Table 7). 
 
 
 
 
      Gait Parameters 
Normal 
Saline 8OH-DPAT 
  p 
value 
Max Contact Area RF 2.44±0.35 1.95±0.66 0.249 
Max Contact Area RH 2.13±0.49 1.4±0.49 0.075 
Max Contact Area LF 2.69±0.36 2.01±0.4 0.046 
Max Contact Area LH 2.09±0.6 1.2±0.5 0.028 
Print Area RF 2.9±0.42 2.3±0.8 0.249 
Print Area RH 2.77±0.58 1.74±0.57 0.046 
Print Area LF 3.11±0.36 2.35±0.47 0.046 
Print Area LH 2.65±0.7 1.5±0.6 0.028 
Body Speed RF 32.9±4.9 29.2±8.6 0.345 
Body Speed RH 31.5±5.1 28.6±8.8 0.249 
Body Speed LF 31.1±5.58 27.3±8.8 0.249 
Body Speed LH 31.7±5.4 28.7±9.2 0.345 
Body Speed Variation RF 50.66±35.7 45.5±15.7 0.917 
Body Speed Variation RH 55.01±40.6 46.9±17 0.753 
Body Speed Variation LF 52.3±36.3 42.8±12.5 0.917 
Body Speed Variation LH 52.26±30.2 47.9±16.9 0.6 
Max Intensity RF 190.4±7.8 169.2±21.8 0.116 
Max Intensity RH 165.8±20 134.2±32.5 0.046 
Max Intensity LF 192.5±7.07 164.9±20.8 0.028 
Max Intensity LH 158.4±28.4 121.6±26.2 0.028 
 
Effect of 5HT2 antagonist, Ketanserin Tartrate injection in GiN on gait. 
In a subsequent experiment, the rats’ baseline gait was recorded after 0.5 µl normal 
saline. Subsequently, the same animals were microinjected in their GiN with 0.5µg/0.5µl 
Ketanserin tartrate, a 5HT2A/2C antagonist (McCool et al., 2014) one hour later, and then 
their gait was studied (see Table 8). The findings suggest that the only gait parameter that 
Table7. Selected dynamic and static gait parameters after 
injection of 8OH-DPAT in GiN.  Mean ± standard deviation 
is measured for each parameter in individual limbs. P values 
< 0.05 are considered significant and are highlighted with 
light green.  
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changed significantly was body speed variation. Therefore, in contrast to 5HT1A 
receptors, 5HT2A/C receptors were demonstrated as not being involved in controlling 
static parameters. 
 
 
 
      Gait Parameters 
Normal 
Saline Ketanserine 
  p 
value 
MaxContactArea RF 3.1±0.5 3.27±0.66 0.463 
MaxContactArea RH 2.7±0.66 2.9±0.9 0.249 
MaxContactArea LF 3.25±0.5 3.21±0.5 0.917 
MaxContactArea LH 2.94±0.9 3.08±0.8 0.6 
PrintArea RF 3.8±0.6 3.88±0.7 0.345 
PrintArea RH 3.6±0.7 3.8±1.09 0.249 
PrintArea LF 3.95±0.7 3.8±0.5 0.6 
PrintArea LH 3.84±1.3 4.01±1.25 0.6 
Body Speed RF 37.8±10.9 39±9.3  
Body Speed RH 34.9±9.6 37.5±9.3 0.917 
Body Speed LF 35.5±10 36±9.7 0.917 
Body Speed LH 37.9±11.6 37.8±9.7 0.917 
Body Speed Variation RF 49.3±18.4 33.7±10.3 0.046 
Body Speed Variation RH 56.2±27.05 37.2±10.6 0.046 
Body Speed Variation LF 47.2±16.7 33.5±10.6 0.046 
Body Speed Variation LH 54.6±20.8 39.1±8.6 0.046 
Max Intensity RF 200.7±3.5 203.4±3.4 0.116 
Max Intensity RH 185±15.2 191±25 0.463 
Max Intensity LF 200.2±7.8 202.7±4.8 0.463 
Max Intensity LH 184.4±26.4 191.8±14.2 0.463 
 
The key findings in this part of the experiment are summarized in Figure 9. 
Table 8. Selected dynamic and static gait parameters.  Mean ± 
standard deviation is measured for each parameter in individual 
limbs. P values < 0.05 are considered significant and are 
highlighted with light green.  
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Immunohistochemistry Labeling for 5HT1A, and 5HT2 Receptors in GiN. 
Here we found that both 5HT1A and 5HT2c receptors are present on the surface of the 
neurons which were previously labeled for CTB injected in CPGs in the lumbar spinal 
cord (Figure 10, and 11). 
 * 
 * 
 * 
 * 
   * 
 * 
 *   * 
 * 
 * 
  * 
Figure9. Key findings of the performance on the Catwalk for dynamic gait 
parameters after injection of normal saline, 5HT1A agonist, and 5HT2 antagonist. 
Graphs show group means ± SEM of selected gait parameters. * p<0.05 
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Figure 10. Double Labeling of GiN 
neurons for CTB tracer, and 5HT1A receptor 
antibody. (A) CTB was injected in CPGs in 
the ventral horn of the spinal cord. CTB 
vesicles in GiN neurons axons and cell 
bodies are seen in this image. (B) GiN 
neurons stained for 5HT1A receptor 
antibody. (C) Double staining of GiN 
neurons for CTB and 5HT1A receptors 
antibody 
A 
B 
C 
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Figure 11. Double Labeling of GiN 
neurons for CTB tracer, and 5HT2C receptor 
antibody. (A) CTB was injected in CPGs in 
ventral horn of the spinal cord. CTB 
vesicles in GiN neurons axons and cell 
bodies are seen in this image. (B) GiN 
neurons stained for 5HT2C  receptor 
antibody. (C) Double staining of GiN 
neurons for CTB and 5HT2c receptors 
antibody. Scale bars = 50 µm 
A 
B 
C 
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4.4 « Discussion » 
The present study provides evidence that GiN descending neurons are controlled by 
serotonergic projections. Among more than 30 known serotonergic receptor subtypes, we 
examined the activity of two main receptors: 5HT1A and 5HT2 family receptors. We 
found that 5HT1A receptors stimulation caused significant decrease in maximum contact 
area, print area, and maximum intensity. Also, 5HT2 receptors inhibition only decreased 
body speed variation significantly. 
Our finding about the role of the GiN in controlling muscle tone is consistent with the 
findings in many previous studies (Hajnik et al., 2000; Karlsson & Blumberg, 2005; Lai 
et al., 2010; Martin et al., 2011; Vetrivelan et al., 2009). However, in almost all of these 
studies, the methods that were used involved electrical stimulation or inhibition of the 
neurons in the GiN. These studies suggested that the GiN causes atonia during REM 
sleep (Vetrivelan et al., 2009). Since the DRN changes its level of activity during 
different sleep cycles (Urbain et al., 2006) and during wakefulness,  it can efficiently 
control GiN neurons. 
In previous chapter, we showed that general inhibition of the DRN by lidocaine resulted 
in impairment of both dynamic and static gait parameters. The dynamic parameters were 
impaired because of the inhibition of DRN serotonergic projections to the motoneurons 
and CPGs in spinal cord. It is possible that the static parameters were impaired due to 
changes in activity of DRN projections to GiN neurons. 
One of the biggest controversies about the MLR or PPN’s role in controlling the 
reticulospinal tract is the lack of evidence demonstrating changes in muscle tone or body 
posture after stimulation or destruction of these structures in numerous studies, which 
were conducted to date (Gut & Winn, 2015; Hernández-Chan et al., 2011; MacLaren et 
al., 2014).  
In a recent study by Gut et al, Catwalk was used to measure different gait parameters in 
the 6-OHDA model of PD rats with partial or complete PPN lesions. They only found 
significant changes in stride length, swing speed, and duty cycle of these rats. These 
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changes improved after posterior PPN deep brain stimulation and worsened with anterior 
PPN stimulation. However, they did not report any changes in any static gait parameters. 
In conclusion, while review of literature about the role of the PPN and MLR in gait 
improvement and control of reticulospinal tract is inconclusive, we found that the DRN is 
a new target which plays an essential role in controlling both muscle tone and dynamic 
parameters of gait. 
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Chapter 5  
5                 «5HT1A Receptors On Mesencephalic Locomotor Region Neurons 
Are Responsible for Dynamic Gait Parameters. » 
 
5.1 « Introduction » 
Shik and colleagues stimulated the dorsal area of the mesopontine junction in 
unconscious decerebrated cats by electrodes. Their research showed that with lower 
frequency stimulation of this area, the animals started to walk. With higher frequency 
stimulation, the walking pattern of movement changed to running and even galloping 
(Shik et al., 1966). Since that time, the dorsal area of the mesopontine junction has been 
identified as the mesencephalic locomotor region (MLR). These findings in cats and 
other similar findings in other species, like rodents and salamander, suggest that the MLR 
is the gait initiation center (Cabelguen et al., 2003; Skinner & Garcia-Rill, 1984).  The 
MLR is part of the reticular formation in the mesopontine junction and includes the 
cuneiform nucleus and pedunculopontine tegmental nucleus (PPN) (Child & Benarroch, 
2013).  
Previous studies suggest that serotonergic projections from the DRN have facilitatory 
effects on motoneurons and CPGs (Noga et al., 2009). In this study, we showed that the 
DRN play an essential role in controlling gait. In fact, inhibition of these neurons by 
lidocaine resulted in severe impairment in animals’ gait (Chapter 3). We also 
demonstrated that the DRN may be responsible in controlling muscle tone in rats by 
sending axons down to the GiN. Therefore, it seems that the DRN is one of the main 
centers of controlling locomotion in vertebrates. Since the MLR is known as an important 
gait initiation center, we hypothesized that the DRN is controlling the MLR through 
5HT1A receptors. To test our hypothesis, we microinjected a 5HT1A agonist 
(8OH_DPAT) in the MLR region bilaterally and then studied the animals’ gait on 
Catwalk. 
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5.2 « Material and Methods » 
Ten male Sprague-Dawley rats (10-12 weeks old), weighing 250-270 grams were used. 
walled cages with free access to food and -slexiglaPRats were individually housed in 
was kept at 22±1 ºC  temperature of the roomment. The water throughout the experi
cycle (lights on from 7 AM to 7PM). dark-on a 12 hour reversed light 
Surgical Procedures 
The animals were anaesthetized with ketamine hydrochloride (Vetalar, initial dose 80 
mg/kg and maintenance dose 40 mg/kg, via intramuscular) and xylazine (0.8 mg/kg, via 
intramuscular). Anesthetized rats were fixed in stereotaxic frame (Kopf Instruments, 
Tajunga, CA) and the incisor bar was adjusted until the anterior and posterior parts of 
skull were at the same level. Stereotaxic coordinates of Paxinos and Watson atlas (2007) 
were used and the reference point was bregma. Indwelling stainless bilateral steel 27-g 
guide cannulae were implanted 1.5 mm above the MLR. The coordinates are in 
millimeters: AP= ˗8, M= ±1.9, DV= ˗7  for MLR. These rats were kept in their cages for 
a 7 days of recovery period. 
Drugs 
8OH-DPAT was purchased from Tocris Cookson (Ellisville, MO, USA). 
Gait Studies 
One day prior to surgery, all rats underwent Catwalk training to familiarize them to the 
walkway and to ensure their ability in conducting successful gait trails.  
 Tight fitting 30-g bilateral injection cannulae were inserted into the guides. They 
protruded 1.5 mm from the guide cannulae to reach the coordinates mentioned above for 
the MLR. Infusions were carried out over 1 minute and the injection cannulae were kept 
in place for another 60 seconds to minimize backflow. 
On the first day of the experiment, 0.5µl of sterile 0.9% saline was injected in MLR. Five 
minutes after the injection the animals were placed on Catwalk glass, where they were 
able to walk freely with their normal pace. For each vehicle or drug injection for each 
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animal, at least three successful gait trials were recorded. A gait trial is considered 
successful if the animal starts walking from one side of the glass plate and finishes its gait 
to the other side of the glass without turning back.  
Baseline gait parameters were recorded after saline injection. An hour after the saline 
injection, 5µM of sterile 8OH-DPAT (Pham-Le et al., 2011) was injected in the MLR. 
Five minutes after the injection the rats were placed on Catwalk and their gait was 
measured.  
Histology 
Upon completion of experiments, animals received an overdose of sodium pentobarbital 
and were perfused transcardially with 0.9% NaCl (containing 1 ml/lit heparin) followed 
by 4% formaldehyde solution (in 0.1 M phosphate buffer). The brains and spinal cords 
were removed and stored in 4% formaldehyde solution for 48 hours and then, 26% 
glycerol solution until they were settled.  
To visualize colocalization of the CTB retrograde tracer (from animals in chapter 2, in 
which CTB was microinjected in CPGs) with 5HT1A in the MLR, 40µm coronal sections 
were cut using a microtome and every fifth section was stained for 5HT1A receptors.  
A rabbit anti-5HT1A primary antibody (SR-1A Antibody, Santa Cruz Biotechnology) and 
a Biotinylated Goat Anti-Rabbit IgG secondary Antibody (Vector Laboratories) were 
used. Then sections were studied under Olympus FV1000 microscope. 
To verify the placement of the cannulae, 0.5µl of a 4% methylene blue solution was 
infused in the MLR. The extension of the dye after half an hour was considered as an 
indication of the presumed diffusion of the normal saline or 8OH-DPAT, which was 
given to each animal during the experiments. In this part of the experiment, 4 animals 
with an inaccurate cannulae site were excluded from our study. 
Statistical Analysis  
In this study, gait parameters of six animals in each group were measured, similar studies 
on Catwalk apparatus have shown that this number of the subjects provides a valid data 
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set (Chuang et al., 2010; Mendes et al., 2015; Vandeputte et al., 2010; Zhou et al., 2015). 
All the recorded videos were double-checked to correct any possible errors that the 
Catwalk software might have made in labeling the paws. All walkway crossings were 
analyzed using the Catwalk software data. Each gait parameter is expressed as mean ± 
S.E.M (Standard error of the mean). SPSS statistical software (version 19) was used to 
analyze all parameters. Statistical significance was evaluated by the  Friedman Test and 
group differences were determined by the non-parametric Wilcoxon test. Since the 
number of the subjects we used in each group of the animals was small (n=6), 
normalization of the data was not appropriate, therefore, we used Wilcoxon test which 
does not assume normality in the data. In this study, a P value lower than 0.05 was 
considered to be statistically significant. 
 
5.3 « Results » 
Verifying Cannulae Placement 
Ten male Sprague-Dawley rats underwent surgery and double cannulas were inserted in 
the MLR (mainly in the PPN). To verify the placement of the cannulas, 1µl of a 4% 
methylene blue solution was infused through the cannulae and half an hour later animals 
were sacrificed. Sections were prepared and the cannulae sites were verified under the 
microscope (Figure12). Four of the animals were excluded due to an inaccurate cannulae 
injection site. 
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Figure12. Cannula site at the MLR. 0.5 µl Methylene blue 4% was microinjected 
through cannula. After making sections Nissl Staining with neutral red color is done on 
the sections. Two upper sections are presenting cannula site at caudal part (Right upper 
image), and rostral part (left upper image) of the MLR in the same animal. Lower images 
are higher magnification of upper sections’ injection site, black arrows show the injection 
site.  
 
Effect of 5HT1A agonist injection in MLR on gait. 
The vehicle’s effect on gait was tested by bilateral injection of 0.5 µl normal saline in the 
MLR and studying the rats’ gait on Catwalk. One hour after vehicle injection, 5µM of 
8OH-DPAT, a 5HT1A receptor agonist was microinjected bilaterally (Pham-Le et al., 
2011) and the rats were placed on Catwalk. While we tested the rats on Catwalk, we 
noticed several mild episodes of freezing of gait in rats. These freezing episodes caused 
significant increase in body speed variation in all four limbs, P= 0.048 (Table9 and 
Figure 13). Stand duration also increased but the swing phase duration did not change 
significantly, which resulted in significant increase in duty cycle, which  Expresses Stand 
as a percentage of Step Cycle . In addition, there was a significant decrease in body 
1mm 
0.5mm 
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speeds and stride length (Table 9). The key findings in this part of the study are 
summarized in Figure 13. 
 
 
 
Dynamic Gait Parameters 
Normal 
Saline 8OH-DPAT P value 
Stand RF 0.3±0.05 0.51±0.14 0.046 
Stand RH 0.35±0.07 0.62±0.14 0.046 
Stand LF 0.3±0.05 0.5±0.17 0.046 
Stand LH 0.3±0.05 0.5±0.17 0.046 
Swing RF 0.16±0.02 0.19±0.03 0.075 
Swing RH 0.13±0.009 0.13±0.009 0.345 
Swing LF 0.16±0.01 0.22±0.03 0.028 
Swing LH 0.12±0.02 0.127±0.001 0.917 
Swing Speed RF 51±8.1 39.8±5.3 0.028 
Swing Speed RH 57.8±7.4 52.3±8.05 0.173 
Swing Speed LF 50.9±7.09 38.4±5.1 0.028 
Swing Speed LH 62.1±9.6 54.1±5.3 0.116 
Stride Length RF 7.46±0.67 6.5±0.73 0.028 
Stride Length RH 7.35±0.63 6.75±0.63 0.028 
Stride Length LF 7.48±0.75 6.45±0.49 0.028 
Stride Length LH 7.5±0.51 6.7±0.55 0.028 
Step Cycle RF 0.46±0.07 0.71±0.14 0.028 
Step Cycle RH 0.46±0.07 0.77±0.18 0.028 
Step Cycle LF 0.47±0.07 0.73±0.16 0.028 
Step Cycle LH 0.46±0.06 0.75±0.15 0.028 
Body Speed RF 15.96±3.07 11.07±2.04 0.028 
Body Speed RH 16.02±3.18 11.6±2.4 0.028 
Body Speed LF 15.76±3.5 11.3±1.9 0.028 
Body Speed LH 15.9±2.6 11.5±1.7 0.028 
Body Speed Variation RF 30.9±13.08 55.8±17.4 0.046 
Body Speed Variation RH 33.09±9.35 59.9±18.09 0.046 
Body Speed Variation LF 31.5±12.3 57.46±16.9 0.046 
Body Speed Variation LH 32.39±12.7 58.68±20.7 0.046 
Duty Cycle RF 64.1±2.66 67.9±4.78 0.046 
Duty Cycle RH 68.5±4.25 76.4±2.38 0.028 
Duty Cycle LF 63.5±2.88 63.7±6.03 0.753 
Duty Cycle LH 70.6±6.06 77.1±3.5 0.028 
Table9. Key Findings after injection of 5HT1A in MLR.  Mean 
± standard deviation is measured for each parameter in 
individual limbs. P values <0.05 are considered significant and 
are highlighted with light green color. 
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Stand Index RF 5.08±0.77 3.01±1.01 0.028 
Stand Index RH 2.94±1.1 2.07±0.5 0.116 
Stand Index LF 5.32±1.46 3.19±0.66 0.028 
Stand Index LH 2.46±0.63 1.67±0.36 0.028 
 
 
 
 
 * *   *  * 
 * 
  * 
  * 
 * 
 * 
 * 
 * 
 *    *  * 
 * 
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Immunohistochemistry Labeling for 5HT1A in MLR. 
After observing significant changes in gait by injection of 5HT1A agonist in the MLR, we 
performed immunohistochemistry studies to find 5HT1A receptors on MLR neurons. 
These neurons were already labeled with CTB injected in CPGs of the lumbar spinal cord 
as described in chapter 2. We found a dense population of 5HT1A receptors in the MLR. 
The images are shown in Figure 14. 
 
 *  * 
*  *   *  * 
 * 
 * 
 * 
Figure13. Key findings of the performance on 
the Catwalk for dynamic gait parameters after 
injection of normal saline, and 5HT1A agonist in 
MLR. Graphs show group means ± SEM of 
selected gait parameters. * p<0.05 
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5.4 « Discussion » 
In this part of the study, we found that 5HT1A receptors on MLR neurons strictly control 
their gait features. Activation of these receptors by 5HT1A agonist, 8OH-DPAT, resulted 
in significant changes in dynamic gait parameters, but none of the static parameters. 
Comparing this data to the results of chapter 3, where we inhibited DRN with lidocaine, 
it seems that the patterns in which these two centers affect dynamic gait parameters are 
different. Inhibition of the DRN resulted in significant increase in duration of both stand 
A 
Figure 14. Double Labeling of the PPN 
neurons for CTB tracer and 5HT1A receptor 
antibody. (A) CTB was injected in CPGs in 
the ventral horn of the spinal cord. CTB 
vesicles in PPN neurons are seen in this 
image. (B) PPN neurons stained for 5HT1A 
receptor antibody. (C) Double staining of 
PPN neurons for CTB and 5HT1A receptors 
antibody. Scale bar = 50µm 
C 
B 
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and swing phases, which lead to increase in step cycle duration. However, since the ratio 
between stand and swing phases remained constant, there was no significant change in 
duty cycle index, which measures stand as a percentage of step cycle. In contrast, 
injection of 5HT1A agonist to the MLR resulted in significant increase in duty cycle due 
to the increase in stand phase without altering swing phase duration.  
In 1966, when Shik and colleagues identified the MLR for the first time, they also 
emphasized a unique property of these neurons: increasing frequency of electrical 
stimulation in these neurons resulted in increased speed (Orlovskiĭ, Severin, & Shik, 
1966; Shik et al., 1966). In other words, by increasing the frequency, these animals 
changed their gait pattern from walking to running, and eventually galloping.  
Biomechanical gait analysis in different speeds showed that an increase in gait speed 
leads to a decrease in stand duration, which decreases duty cycle. Moreover, by 
decreasing the gait speed, stand duration increases and thus, duty cycle increases 
(Hebenstreit et al., 2015). Therefore, biomechanical analysis of our rats gait after 
injection of 5HT1A agonist in the MLR shows that the MLR determines the gait speed. 
One of the main neurotransmitters in controlling the gait speed is serotonin. 
But what makes the MLR and its components (PPN and cuneiform nucleus) appropriate 
to control the gait speed? Recent studies suggest that the posterior part of the PPN 
receives a considerable amount of fast sensory input, which it projects to the substantia 
nigra pars compacta. These projections contain information about the value and salience 
of the incoming sensory information received by the PPN (Hong & Hikosaka, 2014). As 
a result, there is a potential role for PPN in gait due to its essential role in integration of 
sensory information. For instance, MacLaren et al. showed that the PPN is not important 
in fixed speed gait in rats. However, bilateral PPN cholinergic neuronal loss will result in 
severely impaired gait on the accelerated rotarod. Gait on a fixed speed rotarod is 
considered an automatic and reflexive behavior. However, a successful gait on an 
accelerated speed rotarod requires the motor system to continuously adjust to changes 
from incoming sensory inputs. In other words, one of the ways that the PPN adapts gait to 
incoming sensory changes is by altering gait speed, stopping gait and initiating gait.  
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In addition to a significant decrease in body speed, body speed variation increased and 
stride length decreased significantly. These three changes are the essential features of an 
abnormal gait in Parkinson disease patients. There are numerous postmortem studies 
which suggest that there is a significant decrease in both DRN and PPN neurons in 
patients in late stages of PD (Buddhala et al., 2015; Frisina, Haroutunian, & Libow, 2009; 
Pienaar et al., 2013). Therefore, two main gait centers in the brainstem show severe 
neurodegeneration by the time axial and gait symptoms start to emerge in PD patients. 
To sum up, our studies and previous studies suggest that there are two main gait 
controlling centers in the brainstem, the DRN and MLR. The DRN shows the highest 
level of activity during wakefulness (specifically while the animal is moving) and lowest 
level of activity during sleep (specifically during REM sleep when muscles are 
completely atonic) (Aghajanian & Vandermaelen, 1982; Urbain et al., 2006). The DRN is 
also important in footfall pattern and according to the literature, it controls it through 
5HT2 receptors on the surface of motoneurons in the spinal cord (Aghajanian & 
Vandermaelen, 1982; Courtine et al., 2009). Finally, our studies suggest that through 
inhibition of the DRN with lidocaine, the regular footfall pattern disappears. Therefore, 
we conclude that the DRN mainly controls automatic aspects of gait, which are not 
dependent to dynamic changes of sensorimotor inputs. It also acts as a switch which turns 
on or turns off the CPGs in the lumbar spinal cord. This depends on the general state of 
animals in terms of mobility or immobility, as well as sleep and wakefulness. 
On the other hand, the MLR is another brainstem center controlling gait. The MLR 
receives fast sensory inputs from tracks of the spinal cord, in addition to extensive inputs 
from basal ganglia structures such as the subthalamic nucleus and substantia nigra pars 
reticulata. Thus, it seems the MLR mainly controls the aspects of gait that need intact 
cognitive function, decision making, and goal orientation.  
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Chapter 6  
6 «               « Investigating the Role of 5HT1A receptors on Dorsal Raphe Nucleus 
Neurons in Gait. » 
 
6.1 « Introduction » 
Previous studies have established that 5HT1A receptors are expressed on the surface of 
serotonergic neurons in the DRN (Biegon, Rainbow, & McEwen, 1982; Weissmann-
Nanopoulos, Mach, Magre, Demassey, & Pujol, 1985). The number of 5HT1A receptors 
in the anterior part of the DRN is significantly higher than the posterior part (Weissmann-
Nanopoulos et al., 1985), this gradient potentially correlates to the different roles of these 
neurons. The DRN is known to be important in different disorders like depression, 
addiction to drugs and alcohol, sleep disorders, and stress-related disorders (Chang et al., 
2011; Waselus, Valentino, & Van Bockstaele, 2011). Therefore, many studies are 
focusing on the role of 5HT1A receptors in the pathophysiology of these disorders 
(Gannon & Millan, 2006; Koprowska, Krotewicz, Romaniuk, Strzelczuk, & Wieczorek, 
2002; You et al., 2015). 
In previous chapters, we demonstrated that the DRN is controlling two important gait 
centers in the brainstem: the MLR, and GiN. We hypothesized that 5HT1A receptors are 
playing an important role in modulating the activity of DRN neurons in gait. To test our 
hypothesis, we microinjected 8OH-DPAT, a 5HT1A agonist, in the DRN of rats and then 
studied their gait by Catwalk apparatus.  
 
6.2 « Material and Methods » 
Six male Sprague-Dawley rats (10-12 weeks old), weighing 250-270 grams were used. 
walled cages with free access to food and -glasPlexiRats were individually housed in 
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at 22±1 ºC was kept  temperature of the roomwater throughout the experiment. The 
light cycle (lights on from 7 AM to 7PM).-on a 12 hour reversed dark 
 
Surgical Procedures 
chloride (Vetalar, initial dose 80 droyhtamine The animals were anaesthetized with ke
(0.8 mg/kg, ine zylaxand  , via intramuscular)mg/kg and maintenance dose 40 mg/kg
stereotaxic frame (Kopf ). Anesthetized rats were fixed in via intramuscular
Instruments, Tajunga, CA) and the incisor bar was adjusted until the anterior and 
posterior parts of skull were at the same level. Stereotaxic coordinates of Paxinos 
and Watson atlas (2007) were used and the reference point was bregma. Indwelling 
stainless steel 27-g guide cannulae were implanted 1.5 mm above the posterior 
border of DRN. The coordinates are in millimeters: AP= ˗8.3, M=0, DV= ˗6.4 for 
DRN. These rats were kept in their cages for a 7 days of recovery period. 
 
Gait Studies 
One day prior to surgery, all rats underwent Catwalk training to familiarize them to the 
walkway and to ensure their ability in conducting successful gait trails.  
Tight fitting 30-g injection cannulae were inserted into the guides. They protruded 1.5 
mm from the guide cannulae to reach the coordinates mentioned above for the DRN. 
Infusions were carried out over 1 minute and the injection cannulae were kept in place for 
another 60 seconds to minimize backflow. 
During the first day of the experiment, 0.5µl of sterile 0.9% saline was injected in the 
DRN. Five minutes after the injection, the animals were placed on Catwalk, where they 
were able to walk freely with their normal pace. For each vehicle or drug injection of 
each animal, at least three successful gait trials were recorded. A gait trial is considered 
successful if the animal starts walking from one side of the glass plate and finishes its gait 
to the other side of the glass without turning back.  
The vehicle’s effect on gait was tested by bilateral injection of 0.5 µl normal saline in the 
DRN and studying the rats’ gait on Catwalk. An hour after the saline injection, 10µM of 
8OH-DPAT, a 5HT1A receptor agonist, was injected in the DRN. Five minutes after the 
injection, the rats were placed on Catwalk and their gait was measured. 
60 
 
. 
Histology 
Upon completion of experiments, animals received an overdose of sodium pentobarbital 
and were perfused transcardially with 0.9% NaCl (containing 1 ml/lit heparin) followed 
by 4% formaldehyde solution (in 0.1 M phosphate buffer). The brains and spinal cords 
were removed and kept in 4% formaldehyde solution for 48 hours and then, 26% glycerol 
solution until they were settled.  
To visualize colocalization of the CTB retrograde tracer (from animals in chapter 2, in 
which CTB was microinjected in CPGs) with 5HT1A autoreceptors in the DRN, 40µm 
coronal sections were cut using a microtome and every fifth section was stained for 
5HT1A receptors.  
Rabbit anti-5HT1A primary antibody (SR-1A Antibody, Santa Cruz Biotechnology) and a 
Biotinylated Goat Anti-Rabbit IgG secondary Antibody (Vector Laboratories) were used. 
Then sections were studied under Olympus FV1000 microscope. 
To verify the placement of the cannulae, 0.5µl of a 4% methylene blue solution was 
infused in the DRN. The extension of the dye after half an hour was considered as an 
indication of the presumed diffusion of the normal saline or 8OH-DPAT, which was 
given to each animal during the experiments. 
 
Statistical Analysis  
 
In this study, gait parameters of six animals in each group were measured, similar studies 
on Catwalk apparatus have shown that this number of the subjects provides a valid data 
set (Chuang et al., 2010; Mendes et al., 2015; Vandeputte et al., 2010; Zhou et al., 2015). 
All the recorded videos were double-checked to correct any possible errors that the 
Catwalk software might have made in labeling the paws. All walkway crossings were 
analyzed using the Catwalk software data. Each gait parameter is expressed as mean ± 
S.E.M (Standard error of the mean). SPSS statistical software (version 19) was used to 
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analyze all parameters. Statistical significance was evaluated by the  Friedman Test and 
group differences were determined by the non-parametric Wilcoxon test. Since the 
number of the subjects we used in each group of the animals was small (n=6), 
normalization of the data was not appropriate, therefore, we used Wilcoxon test which 
does not assume normality in the data. In this study, a P value lower than 0.05 was 
considered to be statistically significant. 
 
 
 
6.3 « Results » 
Effect of 5HT1A agonist injection in DRN on gait. 
The vehicle’s effect on gait was tested by injection of 0.5 µl normal saline in the DRN 
and studying the rats’ gait on Catwalk. After injection of 10µM 8OH-DPAT, the rats 
were placed on Catwalk and their gait was recorded. Statistical analysis of the data 
showed that swing phase significantly decreased. Additionally, the data demonstrated that 
swing speed increased in all limbs, but was only significant in the right hind and left front 
limbs. There was no significant change in stance phase; however the changes in swing 
and swing speed resulted in increased body speed while the forelimbs were actively 
moving. The key findings are summarized in Table 10 and Figure15. 
 
 
 
Gait Parameters 
Normal 
Saline 8OH-DPAT P Value 
Swing RF 0.271±0.08 0.209±0.04 0.046 
Swing RH 0.187±0.04 0.158±.02 0.046 
Swing LF 0.275±0.1 0.225±0.05 0.468 
Swing LH 0.192±0.06 0.161±0.02 0.435 
Table10. Selected gait parameters after injection of 
8OH-DPAT in the DRN.  Mean ± standard deviation is 
measured for each parameter in individual limbs. P 
values <0.05 are considered significant and are 
highlighted with light green color. 
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Swing Speed RF 96.27±28.06 107.86±28.7 0.075 
Swing Speed RH 122.9±25 131.1±24.6 0.046 
Swing Speed LF 90.4±34.9 112.6±31.9 0.028 
Swing Speed LH 120.41±29.3 130.5±24.8 0.173 
Body Speed RF 29.9±12.4 33.9±12.8 0.046 
Body Speed RH 30.8±11.2 34.38±9.97 0.116 
Body Speed LF 28.8±12.2 33.7±10.6 0.046 
Body Speed LH 30.8±10.1 34.2±9.5 0.116 
 
 
 
 
 
Figure15. Key Findings of the Performance on 
Catwalk for Gait Parameters after injection of 
Normal Saline, and 5HT1A Agonist in DRN. 
Graphs show group means ± SEM of selected 
gait parameters. * p<0.05 
  * 
  *  * 
 * 
  * 
  * 
  * 
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Immunohistochemistry labeling for 5HT1A in MLR. 
After significant changes in gait by injection of 5HT1A agonist in the DRN were found, 
we performed immunohistochemistry studies to find 5HT1A receptors on DRN neurons, 
which were already labeled with CTB injected in the GiN in the second chapter. We 
found 5HT1A receptors on these neurons. The images are shown in Figure 16. 
 
 
 
 
 
A 
B 
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Figure16. Double Labeling of DRN neurons for CTB tracer, and 5HT1A receptors 
antibody. (A) CTB was injected in CPGs in GiN. CTB vesicles in DRN neurons are seen 
in this image. (B) DRN neurons stained for 5HT1A receptor antibody. (C) Double staining 
of DRN neurons for CTB and 5HT1A receptors antibody. Scale bar = 20µm 
 
 
6.4 « Discussion » 
In this part of the study, we found that 5HT1A receptors stimulation in the DRN changed 
swing phases in gait cycle. Swing duration in all limbs decreased, but it was not 
significant in the left front limb. Additionally, swing speed also increased, but they were 
only significant in two limbs: right hind and left front limbs. These changes result in 
increased body speed in anterior limbs while these limbs were actively moving. To avoid 
affecting the MLR which are located anterolateral to DRN, we inserted cannulas in the 
aqueduct canal and the needle tips of the injector cannulas were just touching the dorsal 
border of the DRN. Therefore, there is a possibility that the drug is not distributed to all 
C 
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areas of the DRN and this fact might explain why significant changes in swing phase 
appeared only in some limbs but not all four limbs.  
There is an anteroposterior gradient in the density of 5HT1A receptors. The density is 
higher in the ventral part compared to the dorsal part of the DRN. In chapter two, we 
injected cholera toxin beta subunit, a neural retrograde tracer in the GiN, and we found 
that the neurons which project to the GiN are mostly located in the posterior part of the 
DRN. Therefore, a low density of 5HT1A receptors on serotonergic neurons sending 
projections down to the GiN in our study is consistent with previous studies (Weissmann-
Nanopoulos et al., 1985) 
Since the DRN is known to play a crucial role in controlling sleep/wake cycles, mood, 
, several studies , 2011; Waselus et al., 2011)(Chang et al. , and appetitestress level
are currently focusing on physiological mechanisms that control serotonergic 
neurons in the DRN. 5HT1A receptors are important modulators of serotonergic 
activity in the DRN, and studies have shown that these receptors might play an 
important role in the pathophysiology of disorders like drug and alcohol abuse, sleep 
(Gannon & Millan, 2006; Koprowska et al., 2002; You et  disorders, and depression
DRN are also important in the in receptors  1A. Here we found that 5HTal., 2015)
controlling gait by affecting swing phase. However, due to the low density of these 
receptors on serotonergic neurons that control gait, they might not be as important in 
gait as they are in controlling other DRN functions. 
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Chapter 7  
7   « General Discussion » 
 
The main findings in this study are listed here: 1) The DRN, MLR, and GiN, project 
directly to the ventral horn of the lumbar spinal cord where lower motoneurons and CPGs 
for locomotion are located (Chapter 2). 2) The DRN also sends projections to the GiN, 
however, MLR does not send projections to the GiN (Chapter 2). 3) Inhibition of the 
neurons in the DRN with lidocaine resulted in significant changes in both static and 
dynamic gait parameters (Chapter 3). 3) The DRN affects static gait parameters through 
its projections to the GiN, and 5HT1A receptors on GiN neurons are responsible for this 
effect (Chapter 4). 4) There is a dense population of 5HT1A receptors on MLR, and 
activation of these receptors with 8OH-DPAT, a 5HT1A specific agonist, resulted in 
significant changes in almost all dynamic gait parameters tested but none of the static 
parameters were changed (Chapter 5). 5) 5HT1A receptors are also present on the surface 
of the neurons in the DRN, while their effect on gait was limited to the swing phase of 
the gait cycle (Chapter 6). The main findings of this study are summarized in Figure 17. 
The effect of the direct projections from the DRN to the motoneurons in the ventral horn 
of the spinal cord are well studied (Barreiro-Iglesias et al., 2008; Ghosh & Pearse, 2015), 
and it has been proposed that this pathway might facilitate activation of the motoneurons 
and CPGs. Consequently, by inhibiting DRN neurons directly with lidocaine, we 
expected to see impairment in dynamic gait parameters; however, we found that both 
dynamic and static gait parameters were impaired. 
In addition, DRN neurons projected directly to the lower motoneurons and locomotor 
CPGs in the ventral horn of the spinal cord. We identified a novel pathway from DRN to 
the GiN. The DRN neurons send projections to the medial part of the rostral medulla, 
where GiN is located. Prior literature has shown that electrical stimulation of the neurons 
at GiN, resulted in changes in muscle tone during both sleep, and awake state (Lai et al., 
2010). The discovery of the pathway from the DRN to the GiN in the current study may 
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explain the changes we saw in static gait parameters after injections of the lidocaine in 
the DRN. To clarify the role of this new pathway in gait and to identify the types of the 
serotonergic receptors on GiN neurons, we have investigated the effect of agonists and 
antagonists for 5HT1A and 5HT2 receptors, respectively. The Catwalk study results 
suggested that 5HT1A receptors are at least one of the serotonergic receptors controlling 
the gait parameters in the GiN when animals walk freely.  
Prior studies have shown that PPN and specifically cholinergic neurons in the PPN send 
projections to the GiN (Bachmann et al., 2013; Rye et al., 1988; Skinner & Garcia-Rill, 
1984). Previous studies of the PPN and MLR investigating gait, failed to find changes in 
muscle tone and static gait parameters following destruction, inhibition or stimulation of 
these structures (Bachmann et al., 2013; MacLaren et al., 2014; Smetana et al., 2010; 
Wen et al., 2015). In a recent study, Gut et al. (Gut & Winn, 2015) employed Catwalk 
method to measure different gait parameters in the 6-OHDA model of PD rats with 
partial or complete PPN lesions. They only found significant changes in stride length, 
swing speed, and duty cycle of these rats. These changes improved after posterior PPN 
deep brain stimulation and worsened with anterior PPN stimulation. However, they did 
not report any changes in any static gait parameters. 
In this study, we injected the retrograde tracer CTB in the GiN, but only DRN neurons in 
the mesopontine junction were labeled for the tracer, and the number of the neurons in 
the MLR which were labeled from the tracer was negligible. Although we did not find a 
pathway from the MLR to the GiN, instead, we found that a considerable number of 
neurons in the MLR send direct projections to the lower motor neurons and the CPGs of 
the lumbar spinal cord. In agreement with this, a recent study by Sherman et al. (Sherman 
et al., 2015) showed that the MLR in the mesopontine junction does not send projections 
to the medullary reticular formation, rather sends direct projections down to the spinal 
cord motoneurons. 
We then tested the effect of 5HT1A agonist in the MLR while the animals were walking 
on the Catwalk. We found that the body speed and the stride length were significantly 
decreased. Meanwhile, the ratio between the stand phase duration and the step cycle 
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duration were changed, indicating changes in the gait pattern. These findings might be 
explained by the direct projections from the MLR to the lower motoneurons and CPGs of 
the lumbar spinal cord we found in the present study.  
In addition, PPN also receives extensive inputs from basal ganglia structures such as the 
subthalamic nucleus and substantia nigra pars reticulata (Child & Benarroch, 2013; 
Sherman et al., 2015; Tattersall et al., 2014). As a result, there is a potential role for PPN 
in controlling the aspects of the gait that are dependent on intact decision making and 
cognitive function of the brain.  
To sum up, our results along with previous findings indicate that there are two main gait 
controlling centers in the brainstem, namely, the DRN and MLR (Figure 17). The DRN 
shows the highest level of activity during wakefulness (specially, while the animal is 
moving) and lowest level of activity during sleep (specially, during REM sleep when 
muscles are atonic) (Aghajanian & Vandermaelen, 1982; Urbain et al., 2006). The DRN 
is also important in mediating the foot-fall pattern via 5HT2 receptors on the surface of 
motoneurons in the spinal cord (Aghajanian & Vandermaelen, 1982; Courtine et al., 
2009). Finally, our studies suggest that through inhibition of the DRN with lidocaine, the 
normal foot-fall pattern disappears. Therefore, we conclude that the DRN mainly controls 
automatic aspects of gait, which are not dependent to dynamic changes of sensorimotor 
inputs. In addition, it may act as a switch which turns on or turns off the CPGs in the 
lumbar spinal cord. This depends on the general state of animals in terms of mobility or 
immobility, as well as sleep and wakefulness. 
On the other hand, the MLR is another brainstem center controlling gait. The MLR 
receives fast sensory inputs from the spinal cord, in addition to extensive inputs from 
basal ganglia structures such as the subthalamic nucleus and substantia nigra pars 
reticulata. Thus, it seems that the MLR mainly controls the aspects of gait that require 
intact cognitive function, decision making, and goal-orientated.  
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Parkinsonian gait is characterized as slow gait with short steps. We found the similar gait 
pattern in our rats after the injection of 5HT1A agonist, in the MLR: there was a 
significant decrease in body speed, and stride length, and a significant increase in body 
speed variation. Based on these findings, degeneration of the DRN or PPN or both of 
these structures will result in the abnormal gait pattern we saw after activation of 5HT1A 
receptors in MLR. Post-mortem studies indicate a significant loss of both DRN and PPN 
neurons in late stages of PD (Buddhala et al., 2015; Frisina et al., 2009; Pienaar et al., 
2013). Clinical trials suggest that there are a considerable number of patients who do not 
show improvement in gait and axial symptoms after the deep brain stimulation of the 
PPN. In these patients, degeneration of the DRN neurons might be responsible for these 
symptoms.    
Limitations of the Study 
Figure17. A proposed circuitry controlling gait parameters. DRN sends projections to the 
GiN, ventral horn of the spinal cord and possibly to the MLR. DRN controls the static gait 
parameters through its projections to the GiN, and controls dynamic gait parameters though 
possible projections to the MLR. LMN: Lower Motor Neurons 
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The DRN is located dorsomedial to the MLR. To study the effect of the drugs on DRN 
without affecting the function of the MLR, cannulas targeting the DRN were 
inserted in the aqueduct canal and the tip of the injector cannulas were located near 
the dorsal border of the DRN. The animal’s gait was measured only five minutes 
after the injection, but it is possible that the drugs leak through the aqueduct canal to 
the adjacent structures like the cerebellum. 
While Catwalk apparatus measures many gait parameters, there is no parameter to 
measure the freezing episodes. The only parameter that indirectly indicates the 
freezing episodes is body speed variation which was increased significantly while 
animals had freezing.  However, the Catwalk software is programmed to measure 
the gait parameters when the animals are actively moving, therefore, the effect of 
gait freezing episodes on other gait parameters is not substantial. 
Conclusions 
All these findings together suggest that the DRN serotonergic neurons are one of the 
main controllers of the gait. These neurons send projections to at least three areas: The 
GiN, the ventral horn of the spinal cord, and possibly to the MLR. While they facilitate 
the activity of motoneurons and CPGs through their direct projections to the ventral horn 
of the spinal cord, they modulate static gait parameters through their projections to the 
GiN, and also modulate the dynamic gait parameters through their possible projections to 
the MLR. 
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